Reactive	O
oxygen	O
intermediates	O
as	O
apparently	O
widely	O
used	O
messengers	O
in	O
the	O
activation	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factor	I-protein
and	O
HIV-1	O
.	O

Hydrogen	O
peroxide	O
and	O
oxygen	O
radicals	O
are	O
agents	O
commonly	O
produced	O
during	O
inflammatory	O
processes	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
micromolar	O
concentrations	O
of	O
H2O2	O
can	O
induce	O
the	O
expression	O
and	O
replication	O
of	O
HIV-1	O
in	O
a	O
human	B-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

The	O
effect	O
is	O
mediated	O
by	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	B-protein
factor	I-protein
which	O
is	O
potently	O
and	O
rapidly	O
activated	O
by	O
an	O
H2O2	O
treatment	O
of	O
cells	O
from	O
its	O
inactive	B-protein
cytoplasmic	I-protein
form	I-protein
.	O

N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
,	O
a	O
well	O
characterized	O
antioxidant	O
which	O
counteracts	O
the	O
effects	O
of	O
reactive	O
oxygen	O
intermediates	O
(	O
ROI	O
)	O
in	O
living	O
cells	O
,	O
prevented	O
the	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
H2O2	O
.	O

NAC	O
and	O
other	O
thiol	O
compounds	O
also	O
blocked	O
the	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
by	O
cycloheximide	O
,	O
double-stranded	B-RNA
RNA	I-RNA
,	O
calcium	O
ionophore	O
,	O
TNF-alpha	B-protein
,	O
active	O
phorbol	O
ester	O
,	O
interleukin-1	B-protein
,	O
lipopolysaccharide	O
and	O
lectin	B-protein
.	O

This	O
suggests	O
that	O
diverse	O
agents	O
thought	O
to	O
activate	O
NF-kappa	B-protein
B	I-protein
by	O
distinct	O
intracellular	O
pathways	O
might	O
all	O
act	O
through	O
a	O
common	O
mechanism	O
involving	O
the	O
synthesis	O
of	O
ROI	O
.	O

ROI	O
appear	O
to	O
serve	O
as	O
messengers	O
mediating	O
directly	O
or	O
indirectly	O
the	O
release	O
of	O
the	O
inhibitory	B-protein
subunit	I-protein
I	B-protein
kappa	I-protein
B	I-protein
from	O
NF-kappa	B-protein
B	I-protein
.	O

The	NULL
EMBO	NULL
Journal	NULL
vol.10	NULL
no.8	NULL
pp.2247-	NULL
2258	NULL
,	NULL
1991	NULL
Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
Ralf	NULL
Schreck	NULL
,	NULL
Peter	NULL
Rieber	NULL
'	NULL
and	NULL
Patrick	NULL
A.Baeuerle*	NULL
Laboratorium	NULL
fiir	NULL
Molekulare	NULL
Biologie	NULL
der	NULL
Ludwig-Maximilians-Universitit	NULL
Miinchen	NULL
,	NULL
Genzentrum	NULL
,	NULL
Am	NULL
Klopferspitz	NULL
18a	NULL
,	NULL
D-8033	NULL
Martinsried	NULL
and	NULL
'Institut	NULL
fiir	NULL
Immunologie	NULL
,	NULL
Goethestrasse	NULL
31	NULL
,	NULL
D-8000	NULL
Miinchen	NULL
2	NULL
,	NULL
FRG	NULL
Corresponding	NULL
author	NULL
Communicated	NULL
by	NULL
I.	NULL
W.	NULL
Mattaj	NULL
Hydrogen	NULL
peroxide	NULL
and	NULL
oxygen	NULL
radicals	NULL
are	NULL
agents	NULL
commonly	NULL
produced	NULL
during	NULL
inflammatory	NULL
processes	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
micromolar	NULL
concentrations	NULL
of	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
,	NULL
can	NULL
induce	NULL
the	NULL
expression	NULL
and	NULL
replication	NULL
of	NULL
HIV-1	NULL
in	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
effect	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
which	NULL
is	NULL
potently	NULL
and	NULL
rapidly	NULL
activated	NULL
by	NULL
an	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
of	NULL
cells	NULL
from	NULL
its	NULL
inactive	NULL
cytoplasmic	NULL
form	NULL
.	NULL

N-acetyl-L-cysteine	NULL
(	NULL
NAC	NULL
)	NULL
,	NULL
a	NULL
well	NULL
characterized	NULL
antioxidant	NULL
which	NULL
counteracts	NULL
the	NULL
effects	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
RON	NULL
)	NULL
in	NULL
living	NULL
cells	NULL
,	NULL
prevented	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
;	NULL
0	NULL
,	NULL
.	NULL

NAC	NULL
and	NULL
other	NULL
thiol	NULL
compounds	NULL
also	NULL
blocked	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
cycloheximide	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
calcium	NULL
ionophore	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
active	NULL
phorbol	NULL
ester	NULL
,	NULL
interleukin-1	NULL
,	NULL
lipopolysaccharide	NULL
and	NULL
lectin	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
diverse	NULL
agents	NULL
thought	NULL
to	NULL
activate	NULL
NF-xB	NULL
by	NULL
distinct	NULL
intracellular	NULL
pathways	NULL
might	NULL
all	NULL
act	NULL
through	NULL
a	NULL
common	NULL
mechanism	NULL
involving	NULL
the	NULL
synthesis	NULL
of	NULL
ROI	NULL
.	NULL

ROI	NULL
appear	NULL
to	NULL
serve	NULL
as	NULL
messengers	NULL
mediating	NULL
directly	NULL
or	NULL
indirectly	NULL
the	NULL
release	NULL
of	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
from	NULL
NF-xB	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
N-acetyl-L-cysteine/activation	NULL
of	NULL
NF-xB/	NULL
HIV-1/hydrogen	NULL
peroxide/NF-xB	NULL
Introduction	NULL
NF-xB	NULL
is	NULL
a	NULL
multisubunit	NULL
transcription	NULL
factor	NULL
that	NULL
can	NULL
rapidly	NULL
activate	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
inflammatory	NULL
,	NULL
immune	NULL
and	NULL
acute	NULL
phase	NULL
responses	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1991	NULL
;	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
is	NULL
found	NULL
in	NULL
many	NULL
different	NULL
cell	NULL
types	NULL
and	NULL
tissues	NULL
but	NULL
has	NULL
been	NULL
characterized	NULL
best	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
such	NULL
as	NULL
pre-B	NULL
,	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
,	NULL
macrophages	NULL
and	NULL
monocytes	NULL
.	NULL

Many	NULL
target	NULL
genes	NULL
of	NULL
the	NULL
ubiquitous	NULL
NF-xB	NULL
show	NULL
a	NULL
tissue-or	NULL
cell	NULL
type-specific	NULL
expression	NULL
which	NULL
might	NULL
come	NULL
from	NULL
a	NULL
synergistic	NULL
action	NULL
of	NULL
NF-xB	NULL
with	NULL
cell	NULL
type-specific	NULL
factors	NULL
within	NULL
enhancers	NULL
and	NULL
promoters	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
target	NULL
genes	NULL
fall	NULL
into	NULL
three	NULL
classes	NULL
:	NULL
genes	NULL
encoding	NULL
(	NULL
i	NULL
)	NULL
immunomodulatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-6	NULL
,	NULL
3-interferon	NULL
and	NULL
GM-CSF	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
immunoregulatory	NULL
cell	NULL
surface	NULL
receptors	NULL
such	NULL
as	NULL
MHC	NULL
class	NULL
I	NULL
antigens	NULL
,	NULL
non-polymorphic	NULL
subunits	NULL
of	NULL
MHC	NULL
genes	NULL
and	NULL
the	NULL
IL-2	NULL
cytokine	NULL
receptor	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
acute	NULL
phase	NULL
proteins	NULL
such	NULL
as	NULL
serum	NULL
amyloid	NULL
A	NULL
precursor	NULL
and	NULL
angiotensinogen	NULL
.	NULL

In	NULL
most	NULL
cells	NULL
,	NULL
NF-xB	NULL
is	NULL
present	NULL
in	NULL
a	NULL
non-DNA-binding	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
three	NULL
subunits	NULL
:	NULL
a	NULL
DNA-binding	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
48-55	NULL
kd	NULL
protein	NULL
(	NULL
p50	NULL
)	NULL
(	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
a	NULL
DNA-binding	NULL
65-68	NULL
kd	NULL
protein	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Urban	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
a	NULL
third	NULL
inhibitory	NULL
subunit	NULL
,	NULL
called	NULL
IxB	NULL
,	NULL
which	NULL
is	NULL
bound	NULL
to	NULL
p65	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988b	NULL
;	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Urban	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

IxB	NULL
inhibits	NULL
DNA-binding	NULL
of	NULL
NF-xB	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
cytoplasmic	NULL
localization	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988b	NULL
)	NULL
.	NULL

It	NULL
is	NULL
apparently	NULL
the	NULL
release	NULL
of	NULL
IxB	NULL
which	NULL
triggers	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
.	NULL

Recent	NULL
molecular	NULL
cloning	NULL
of	NULL
the	NULL
p50	NULL
(	NULL
Bours	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
and	NULL
p65	NULL
subunits	NULL
(	NULL
Ruben	NULL
eral	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
revealed	NULL
that	NULL
their	NULL
DNA-binding/dimerization	NULL
domains	NULL
share	NULL
high	NULL
homology	NULL
with	NULL
that	NULL
of	NULL
the	NULL
rel	NULL
proto-oncogene	NULL
proteins	NULL
.	NULL

There	NULL
is	NULL
at	NULL
least	NULL
one	NULL
more	NULL
c-rel/NF-xB-like	NULL
protein	NULL
with	NULL
a	NULL
molecular	NULL
size	NULL
of	NULL
75	NULL
kd	NULL
(	NULL
p75	NULL
)	NULL
(	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

p50	NULL
can	NULL
associate	NULL
with	NULL
c-rel	NULL
and	NULL
p75	NULL
after	NULL
a	NULL
combined	NULL
renaturation	NULL
in	NULL
vitro	NULL
but	NULL
it	NULL
is	NULL
unclear	NULL
yet	NULL
whether	NULL
this	NULL
can	NULL
occur	NULL
in	NULL
vivo	NULL
as	NULL
well	NULL
.	NULL

A	NULL
characteristic	NULL
of	NULL
NF-xB	NULL
is	NULL
that	NULL
many	NULL
different	NULL
agents	NULL
can	NULL
induce	NULL
its	NULL
DNA-binding	NULL
activity	NULL
(	NULL
reviewed	NULL
in	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1991	NULL
;	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
are	NULL
viruses	NULL
(	NULL
which	NULL
can	NULL
activate	NULL
NF-xB	NULL
either	NULL
by	NULL
the	NULL
action	NULL
of	NULL
viral	NULL
transactivator	NULL
proteins	NULL
or	NULL
double-stranded	NULL
RNA	NULL
intermediates	NULL
)	NULL
,	NULL
bacterial	NULL
lipopolysaccharide	NULL
,	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
,	NULL
the	NULL
cytokines	NULL
TNF-a	NULL
,	NULL
TNF-	NULL
and	NULL
interleukin-1	NULL
,	NULL
and	NULL
T	NULL
cell	NULL
mitogens	NULL
,	NULL
such	NULL
as	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
lectins	NULL
,	NULL
calcium	NULL
ionophores	NULL
and	NULL
antibodies	NULL
directed	NULL
against	NULL
T	NULL
cell	NULL
receptors	NULL
.	NULL

Very	NULL
little	NULL
is	NULL
known	NULL
of	NULL
how	NULL
such	NULL
diverse	NULL
agents	NULL
can	NULL
all	NULL
cause	NULL
the	NULL
same	NULL
reaction	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
release	NULL
of	NULL
IxB	NULL
from	NULL
p50-p65	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

Some	NULL
progress	NULL
was	NULL
recently	NULL
made	NULL
in	NULL
understanding	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
PMA	NULL
,	NULL
an	NULL
activator	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
of	NULL
PKC	NULL
with	NULL
cytoplasm	NULL
(	NULL
Shirakawa	NULL
and	NULL
Mizel	NULL
,	NULL
1989	NULL
)	NULL
or	NULL
partially	NULL
purified	NULL
NF-xB-IxB	NULL
complex	NULL
(	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
under	NULL
kinasing	NULL
conditions	NULL
caused	NULL
an	NULL
activation	NULL
of	NULL
the	NULL
DNA-binding	NULL
of	NULL
NF-xB	NULL
.	NULL

Furthermore	NULL
,	NULL
treatment	NULL
of	NULL
purified	NULL
IxB	NULL
with	NULL
PKC	NULL
inactivated	NULL
the	NULL
inhibitor	NULL
and	NULL
the	NULL
incorporation	NULL
of	NULL
radioactive	NULL
phosphate	NULL
into	NULL
a	NULL
protein	NULL
of	NULL
the	NULL
molecular	NULL
size	NULL
of	NULL
IxB	NULL
was	NULL
observed	NULL
(	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
a	NULL
direct	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
through	NULL
PKC	NULL
released	NULL
the	NULL
inhibitor	NULL
and	NULL
thereby	NULL
activated	NULL
NF-xB	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
TNF-	NULL
«	NULL
appears	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
PKC	NULL
(	NULL
Meichle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Although	NULL
TNF	NULL
induces	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
activation	NULL
of	NULL
PKC	NULL
(	NULL
Schiitze	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
depletion	NULL
of	NULL
the	NULL
kinase	NULL
by	NULL
chronic	NULL
PMA	NULL
treatment	NULL
and	NULL
the	NULL
use	NULL
of	NULL
PKC	NULL
inhibitors	NULL
did	NULL
not	NULL
affect	NULL
NF-xB	NULL
activation	NULL
by	NULL
TNF	NULL
.	NULL

Also	NULL
the	NULL
NF-xB	NULL
activation	NULL
by	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
and	NULL
double-stranded	NULL
RNA	NULL
(	NULL
Visvanathan	NULL
and	NULL
Goodbourn	NULL
,	NULL
1989	NULL
;	NULL
Lenardo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
PKC	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
Roederer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
reported	NULL
that	NULL
N-acetyl-L-cysteine	NULL
(	NULL
NAC	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
the	NULL
PMA	NULL
2247	NULL
R.Schreck	NULL
,	NULL
P.Rieber	NULL
and	NULL
P.A.Baeuerle	NULL
and	NULL
TNF-	NULL
&	NULL
-induced	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

While	NULL
our	NULL
study	NULL
was	NULL
in	NULL
progress	NULL
,	NULL
a	NULL
second	NULL
study	NULL
from	NULL
the	NULL
Herzenberg	NULL
laboratory	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
showed	NULL
that	NULL
NAC	NULL
blocked	NULL
specifically	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

The	NULL
authors	NULL
suggested	NULL
that	NULL
the	NULL
intracellular	NULL
glutathione	NULL
(	NULL
GSH	NULL
)	NULL
level	NULL
,	NULL
which	NULL
is	NULL
increased	NULL
by	NULL
NAC	NULL
,	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
NF-xB	NULL
.	NULL

Because	NULL
GSH	NULL
levels	NULL
control	NULL
the	NULL
concentration	NULL
of	NULL
ROI	NULL
within	NULL
cells	NULL
via	NULL
the	NULL
GSH	NULL
peroxidase	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Halliwell	NULL
and	NULL
Gutteridge	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
we	NULL
were	NULL
prompted	NULL
to	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
oxygen	NULL
radicals	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

We	NULL
used	NULL
H	NULL
;	NULL
O	NULL
;	NULL
as	NULL
a	NULL
membrane-permeable	NULL
reagent	NULL
which	NULL
allows	NULL
studies	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
oxygen	NULL
radicals	NULL
in	NULL
living	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
H	NULL
,	NULL
O	NULL
;	NULL
is	NULL
physiologically	NULL
produced	NULL
in	NULL
large	NULL
amounts	NULL
by	NULL
granulocytes	NULL
and	NULL
macrophages	NULL
during	NULL
inflammatory	NULL
processes	NULL
and	NULL
is	NULL
implicated	NULL
,	NULL
together	NULL
with	NULL
oxygen	NULL
radicals	NULL
,	NULL
in	NULL
many	NULL
pathological	NULL
situations	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Cerutti	NULL
,	NULL
1985	NULL
;	NULL
Blake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Halliwell	NULL
and	NULL
Gutteridge	NULL
,	NULL
1989	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
report	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
micromolar	NULL
amounts	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
.	NULL

The	NULL
same	NULL
treatment	NULL
could	NULL
also	NULL
potently	NULL
transactivate	NULL
the	NULL
enhancer/promoter	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
depending	NULL
on	NULL
intact	NULL
binding	NULL
sites	NULL
for	NULL
NF-xB	NULL
,	NULL
and	NULL
increase	NULL
the	NULL
production	NULL
of	NULL
new	NULL
HIV-1	NULL
virus	NULL
in	NULL
latently	NULL
infected	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
antioxidant	NULL
and	NULL
radical	NULL
scavenger	NULL
NAC	NULL
inhibited	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
strongly	NULL
supporting	NULL
the	NULL
idea	NULL
that	NULL
oxygen	NULL
radicals	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
process	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
cycloheximide	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
bacterial	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
calcium	NULL
ionophore	NULL
,	NULL
lectin	NULL
and	NULL
,	NULL
as	NULL
reported	NULL
earlier	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
by	NULL
TNF-a	NULL
and	NULL
PMA	NULL
,	NULL
was	NULL
strongly	NULL
inhibited	NULL
by	NULL
NAC	NULL
.	NULL

Also	NULL
other	NULL
thiol	NULL
compounds	NULL
blocked	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
the	NULL
effect	NULL
was	NULL
not	NULL
restricted	NULL
to	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
could	NULL
provide	NULL
a	NULL
unifying	NULL
concept	NULL
of	NULL
how	NULL
many	NULL
different	NULL
agents	NULL
can	NULL
induce	NULL
the	NULL
DNA-binding	NULL
of	NULL
the	NULL
cytoplasmic	NULL
form	NULL
of	NULL
NF-xB	NULL
:	NULL
ROI	NULL
,	NULL
which	NULL
can	NULL
transiently	NULL
increase	NULL
in	NULL
cells	NULL
by	NULL
different	NULL
mechanisms	NULL
,	NULL
could	NULL
serve	NULL
as	NULL
messengers	NULL
that	NULL
directly	NULL
or	NULL
indirectly	NULL
cause	NULL
the	NULL
release	NULL
of	NULL
IxB	NULL
from	NULL
the	NULL
p50-p65-IxB	NULL
complex	NULL
.	NULL

Results	NULL
Treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
activates	NULL
NF-xB	NULL
Jurkat	NULL
T	NULL
cells	NULL
are	NULL
widely	NULL
used	NULL
in	NULL
the	NULL
study	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
processes	NULL
and	NULL
provide	NULL
a	NULL
model	NULL
system	NULL
for	NULL
studying	NULL
the	NULL
induction	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
latently	NULL
infected	NULL
cells	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
human	NULL
T	NULL
lymphoma	NULL
cell	NULL
line	NULL
responds-to	NULL
treatments	NULL
with	NULL
the	NULL
active	NULL
phorbol	NULL
ester	NULL
PMA	NULL
,	NULL
lectins	NULL
and	NULL
TNF	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
NF-xB-controlled	NULL
genes	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
tested	NULL
hydrogen	NULL
peroxide	NULL
,	NULL
an	NULL
agent	NULL
produced	NULL
during	NULL
inflammatory	NULL
processes	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Halliwell	NULL
and	NULL
Gutteridge	NULL
,	NULL
1989	NULL
)	NULL
,	NULL
for	NULL
its	NULL
capability	NULL
to	NULL
activate	NULL
NF-xB	NULL
.	NULL

Because	NULL
H	NULL
,	NULL
O	NULL
;	NULL
can	NULL
permeate	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
can	NULL
be	NULL
converted	NULL
intracellularly	NULL
into	NULL
more	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
,	NULL
it	NULL
allows	NULL
investigation	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
of	NULL
oxygen	NULL
radicals	NULL
in	NULL
living	NULL
cells	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
150	NULL
4M	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

After	NULL
various	NULL
times	NULL
,	NULL
aliquots	NULL
of	NULL
the	NULL
cell	NULL
culture	NULL
were	NULL
harvested	NULL
and	NULL
cells	NULL
fractionated	NULL
into	NULL
cytosol	NULL
and	NULL
nuclei	NULL
.	NULL

Nuclear	NULL
salt	NULL
extracts	NULL
and	NULL
cytosol	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
specific	NULL
DNA-binding	NULL
of	NULL
NF-xB	NULL
using	NULL
2248	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
an	NULL
H	NULL
;	NULL
O	NULL
;	NULL
treatment	NULL
on	NULL
DNA-binding	NULL
activities	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Rapid	NULL
induction	NULL
of	NULL
a	NULL
x	NULL
enhancer-binding	NULL
protein	NULL
by	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Co	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
or	NULL
incubated	NULL
for	NULL
various	NULL
times	NULL
with	NULL
150	NULL
«	NULL
M	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
,	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
and	NULL
cytosolic	NULL
fractions	NULL
(	NULL
lanes	NULL
8-13	NULL
)	NULL
were	NULL
prepared	NULL
and	NULL
equal	NULL
proportions	NULL
(	NULL
2-8	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
reacted	NULL
with	NULL
a	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
encompassing	NULL
the	NULL
xB	NULL
motif	NULL
of	NULL
the	NULL
mouse	NULL
x	NULL
light	NULL
chain	NULL
enhancer	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

A	NULL
protein-DNA	NULL
complex	NULL
with	NULL
purified	NULL
NF-xB	NULL
composed	NULL
of	NULL
pSO	NULL
and	NULL
p65	NULL
subunits	NULL
(	NULL
Bacuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
)	NULL
was	NULL
electrophoresed	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

A	NULL
fluorogram	NULL
of	NULL
the	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
filled	NULL
arrowhead	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
a	NULL
NF-xB-DNA	NULL
complex	NULL
and	NULL
the	NULL
open	NULL
arrowhead	NULL
the	NULL
position	NULL
of	NULL
unbound	NULL
DNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Dose	NULL
dependence	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
long-term	NULL
incubation	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
and	NULL
16	NULL
h	NULL
with	NULL
either	NULL
30	NULL
,	NULL
50	NULL
or	NULL
100	NULL
4M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

The	NULL
radioactivity	NULL
in	NULL
the	NULL
induced	NULL
protein-DNA	NULL
complex	NULL
co-migrating	NULL
with	NULL
that	NULL
of	NULL
NF-xB	NULL
was	NULL
determined	NULL
by	NULL
Cerenkov	NULL
counting	NULL
and	NULL
the	NULL
numbers	NULL
corrected	NULL
for	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
protein	NULL
.	NULL

electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1A	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
rapidly	NULL
activated	NULL
an	NULL
activity	NULL
that	NULL
retarded	NULL
in	NULL
native	NULL
gels	NULL
a	NULL
*°P-labeled	NULL
DNA	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
H	NULL
,	NULL
O	NULL
;	NULL
-induced	NULL
DNA-binding	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
competition	NULL
analysis	NULL
.	NULL

A	NULL
nuclear	NULL
extract	NULL
from	NULL
H	NULL
,	NULL
O	NULL
;	NULL
-treated	NULL
(	NULL
100	NULL
aM	NULL
;	NULL
3	NULL
h	NULL
)	NULL
Jurkat	NULL
cells	NULL
was	NULL
used	NULL
.	NULL

2.5-	NULL
,	NULL
25-	NULL
and	NULL
250-fold	NULL
molar	NULL
excesses	NULL
of	NULL
unlabeled	NULL
competitor	NULL
olifonucleotides	NULL
(	NULL
described	NULL
in	NULL
Zabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
the	NULL
``	NULL
P-labeled	NULL
x	NULL
enhancer	NULL
probe	NULL
and	NULL
the	NULL
binding	NULL
reaction	NULL
started	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
competitor	NULL
oligonucleotide	NULL
encompassed	NULL
the	NULL
NF-xB	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
&	NULL
chain	NULL
promoter	NULL
,	NULL
'IL-2R	NULL
mu	NULL
'	NULL
is	NULL
the	NULL
same	NULL
oligonucleotide	NULL
with	NULL
two	NULL
point	NULL
mutations	NULL
(	NULL
see	NULL
text	NULL
)	NULL
,	NULL
and	NULL
'unr	NULL
'	NULL
is	NULL
an	NULL
unrelated	NULL
DNA	NULL
fragment	NULL
described	NULL
in	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

A	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
filled	NULL
arrowhead	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
xB-specific	NULL
DNA-binding	NULL
activity	NULL
and	NULL
arrows	NULL
the	NULL
positions	NULL
of	NULL
two	NULL
non-specific	NULL
(	NULL
n.s	NULL
.	NULL
)	NULL

activities	NULL
.	NULL

The	NULL
open	NULL
arrowhead	NULL
shows	NULL
the	NULL
position	NULL
of	NULL
unbound	NULL
DNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoreactivity	NULL
of	NULL
the	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-inducible	NULL
protein-DNA	NULL
complex	NULL
.	NULL

Purified	NULL
human	NULL
NF-xB	NULL
(	NULL
Zabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
and	NULL
7	NULL
)	NULL
and	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
50	NULL
#	NULL
M	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
1	NULL
h	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
and	NULL
8	NULL
)	NULL
were	NULL
reacted	NULL
with	NULL
a	NULL
mix	NULL
of	NULL
pre-immune	NULL
sera	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-xB	NULL
(	NULL
no	NULL
.	NULL

2	NULL
;	NULL
Kieran	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
an	NULL
antiserum	NULL
reacting	NULL
with	NULL
the	NULL
unique	NULL
C-terminus	NULL
of	NULL
the	NULL
human	NULL
c-rel	NULL
protein	NULL
(	NULL
Brownell	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

After	NULL
immunoreaction	NULL
,	NULL
the	NULL
DNA	NULL
probe	NULL
was	NULL
added	NULL
together	NULL
with	NULL
a	NULL
DNA-binding	NULL
mix	NULL
and	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
native	NULL
gel	NULL
.	NULL

A	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

Lanes	NULL
9-11	NULL
show	NULL
a	NULL
slowly	NULL
migrating	NULL
binding	NULL
activity	NULL
from	NULL
the	NULL
serum	NULL
labeled	NULL
with	NULL
an	NULL
arrow	NULL
(	NULL
S	NULL
)	NULL
.	NULL

Lane	NULL
12	NULL
shows	NULL
the	NULL
DNA-binding	NULL
mix	NULL
without	NULL
additions	NULL
.	NULL

A	NULL
bracket	NULL
on	NULL
the	NULL
left	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
immune-complexed	NULL
NF-xB	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
10	NULL
ug/ml	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
50	NULL
ug/ml	NULL
cycloheximide	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
50	NULL
1M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Lanes	NULL
6	NULL
and	NULL
7	NULL
show	NULL
a	NULL
combined	NULL
treatment	NULL
of	NULL
50	NULL
1M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
with	NULL
10	NULL
and	NULL
50	NULL
ug/ml	NULL
CHX	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
protein-DNA	NULL
complex	NULL
of	NULL
purifed	NULL
NF-xB	NULL
was	NULL
electrophoresed	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

A	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

probe	NULL
encompassing	NULL
the	NULL
decameric	NULL
NF-xB	NULL
motif	NULL
from	NULL
the	NULL
mouse	NULL
x	NULL
light	NULL
chain	NULL
enhancer	NULL
.	NULL

The	NULL
newly	NULL
activated	NULL
protein-DNA	NULL
complex	NULL
co-migrated	NULL
with	NULL
that	NULL
formed	NULL
by	NULL
purified	NULL
human	NULL
NF-xB	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
protein	NULL
subunits	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

More	NULL
conclusive	NULL
evidence	NULL
for	NULL
the	NULL
H	NULL
;	NULL
,	NULL
O	NULL
,	NULL
-activated	NULL
factor	NULL
being	NULL
NF-xB	NULL
came	NULL
from	NULL
a	NULL
binding	NULL
competition	NULL
analysis	NULL
and	NULL
an	NULL
immunoreactivity	NULL
experiment	NULL
shown	NULL
below	NULL
(	NULL
see	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-xB	NULL
by	NULL
oxidant	NULL
stress	NULL
In	NULL
cytosolic	NULL
fractions	NULL
,	NULL
no	NULL
accumulation	NULL
of	NULL
the	NULL
H	NULL
,	NULL
O	NULL
;	NULL
-activated	NULL
protein-DNA	NULL
complex	NULL
was	NULL
seen	NULL
(	NULL
Figure	NULL
1B	NULL
,	NULL
lanes	NULL
9-13	NULL
)	NULL
indicating	NULL
that	NULL
the	NULL
newly	NULL
activated	NULL
NF-xB	NULL
was	NULL
rapidly	NULL
translocated	NULL
from	NULL
the	NULL
cytoplasm	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

None	NULL
of	NULL
the	NULL
faster	NULL
migrating	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
x	NULL
enhancer	NULL
probe	NULL
was	NULL
affected	NULL
by	NULL
the	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
-treatment	NULL
of	NULL
cells	NULL
indicating	NULL
that	NULL
the	NULL
activation	NULL
was	NULL
specific	NULL
for	NULL
NF-xB	NULL
and	NULL
did	NULL
not	NULL
reduce	NULL
the	NULL
DNA-binding	NULL
of	NULL
other	NULL
proteins	NULL
(	NULL
see	NULL
also	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Also	NULL
concentrations	NULL
<	NULL
150	NULL
uM	NULL
H	NULL
,	NULL
O	NULL
;	NULL
could	NULL
efficiently	NULL
activate	NULL
NF-xB	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

A	NULL
kinetic	NULL
analysis	NULL
showed	NULL
that	NULL
a	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
30	NULL
LM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
accumulated	NULL
significant	NULL
amounts	NULL
of	NULL
active	NULL
NF-xB	NULL
in	NULL
nuclei	NULL
.	NULL

With	NULL
25	NULL
4M	NULL
H	NULL
;	NULL
0	NULL
;	NULL
,	NULL
no	NULL
significant	NULL
activation	NULL
was	NULL
seen	NULL
after	NULL
4	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
observed	NULL
some	NULL
variation	NULL
between	NULL
experiments	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
minimal	NULL
concentration	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
that	NULL
induced	NULL
NF-xB	NULL
activity	NULL
.	NULL

This	NULL
could	NULL
be	NULL
due	NULL
to	NULL
different	NULL
extents	NULL
of	NULL
decomposition	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
in	NULL
the	NULL
cell	NULL
culture	NULL
medium	NULL
catalyzed	NULL
by	NULL
either	NULL
serum	NULL
components	NULL
(	NULL
Link	NULL
and	NULL
Riley	NULL
,	NULL
1988	NULL
)	NULL
or	NULL
enzymes	NULL
released	NULL
from	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
and	NULL
100	NULL
LM	NULL
H	NULL
;	NULL
0	NULL
;	NULL
,	NULL
,	NULL
more	NULL
NF-xB	NULL
was	NULL
activated	NULL
after	NULL
4	NULL
h	NULL
than	NULL
with	NULL
30	NULL
gM	NULL
.	NULL

After	NULL
16	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
a	NULL
slight	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
active	NULL
nuclear	NULL
NF-xB	NULL
was	NULL
seen	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

There	NULL
was	NULL
only	NULL
a	NULL
small	NULL
difference	NULL
between	NULL
the	NULL
activation	NULL
potential	NULL
of	NULL
50	NULL
and	NULL
100	NULL
4M	NULL
H	NULL
;	NULL
,	NULL
O0	NULL
;	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
maximal	NULL
stimulation	NULL
of	NULL
NF-xB	NULL
was	NULL
reached	NULL
between	NULL
50	NULL
and	NULL
100	NULL
aM	NULL
.	NULL

Prolonged	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
concentrations	NULL
>	NULL
150	NULL
uM	NULL
significantly	NULL
decreased	NULL
the	NULL
survival	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
was	NULL
observed	NULL
with	NULL
other	NULL
cell	NULL
lines	NULL
too	NULL
(	NULL
Link	NULL
and	NULL
Riley	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

H	NULL
,	NULL
O	NULL
;	NULL
could	NULL
also	NULL
activate	NULL
NF-xB	NULL
in	NULL
various	NULL
other	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
among	NULL
them	NULL
the	NULL
mouse	NULL
fibroblast	NULL
line	NULL
Ltk~	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
and	NULL
the	NULL
pre-B	NULL
cell	NULL
line	NULL
702/3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
possible	NULL
identity	NULL
of	NULL
the	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-activated	NULL
DNA-binding	NULL
protein	NULL
with	NULL
NF-xB	NULL
was	NULL
further	NULL
investigated	NULL
by	NULL
a	NULL
binding	NULL
competition	NULL
analysis	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
and	NULL
by	NULL
the	NULL
use	NULL
of	NULL
antisera	NULL
specific	NULL
for	NULL
the	NULL
DNA-binding	NULL
p50	NULL
subunit	NULL
of	NULL
NF-xB	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
H	NULL
,	NULL
O	NULL
;	NULL
were	NULL
reacted	NULL
with	NULL
a	NULL
P-labeled	NULL
x	NULL
enhancer	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
various	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
lanes	NULL
2-10	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
a	NULL
250-fold	NULL
molar	NULL
excess	NULL
of	NULL
an	NULL
oligonucleotide	NULL
encompassing	NULL
the	NULL
NF-xB	NULL
binding	NULL
motif	NULL
5-GGGAATCTCC-3	NULL
'	NULL
from	NULL
the	NULL
IL-2R	NULL
promoter	NULL
completely	NULL
eliminated	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
radioactive	NULL
protein-DNA	NULL
complex	NULL
induced	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
treatment	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

At	NULL
a	NULL
250-fold	NULL
molar	NULL
excess	NULL
,	NULL
the	NULL
competition	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
a	NULL
mutant	NULL
xB	NULL
motif	NULL
from	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
promoter	NULL
(	NULL
5'-GGGAATCTAA-3	NULL
``	NULL
)	NULL
showed	NULL
only	NULL
a	NULL
weak	NULL
effect	NULL
on	NULL
binding	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
which	NULL
does	NULL
not	NULL
contain	NULL
sequences	NULL
similar	NULL
to	NULL
xB	NULL
motifs	NULL
showed	NULL
no	NULL
competition	NULL
within	NULL
the	NULL
concentration	NULL
range	NULL
tested	NULL
(	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
the	NULL
xB-specific	NULL
DNA-binding	NULL
of	NULL
the	NULL
H	NULL
,	NULL
O	NULL
;	NULL
-activated	NULL
factor	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
two	NULL
minor	NULL
activities	NULL
to	NULL
the	NULL
radioactive	NULL
DNA	NULL
probe	NULL
was	NULL
not	NULL
strongly	NULL
influenced	NULL
by	NULL
any	NULL
of	NULL
the	NULL
competitor	NULL
oligonucleotides	NULL
demonstrating	NULL
that	NULL
their	NULL
DNA-binding	NULL
was	NULL
not	NULL
sequence-specific	NULL
.	NULL

These	NULL
activities	NULL
must	NULL
have	NULL
been	NULL
endogenous	NULL
because	NULL
they	NULL
were	NULL
not	NULL
detectable	NULL
in	NULL
a	NULL
reaction	NULL
without	NULL
nuclear	NULL
extract	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
H	NULL
,	NULL
O	NULL
;	NULL
,	NULL
-activated	NULL
protein-DNA	NULL
complex	NULL
could	NULL
react	NULL
with	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
DNA-binding	NULL
p50	NULL
subunit	NULL
of	NULL
NF-xB	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
serum	NULL
did	NULL
not	NULL
cross-react	NULL
with	NULL
the	NULL
related	NULL
2249	NULL
R.Schreck	NULL
,	NULL
P.Rieber	NULL
and	NULL
P.A.Baeuerle	NULL
c-rel	NULL
protein	NULL
in	NULL
EMSAs	NULL
(	NULL
U.Zabel	NULL
and	NULL
P.Baeuerle	NULL
,	NULL
unpublished	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
anti-p50	NULL
serum	NULL
during	NULL
the	NULL
DNA-binding	NULL
reaction	NULL
abolished	NULL
the	NULL
protein-DNA	NULL
complex	NULL
of	NULL
purified	NULL
NF-xB	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
co-migrating	NULL
inducible	NULL
complex	NULL
from	NULL
a	NULL
nuclear	NULL
extract	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
-treated	NULL
Jurkat	NULL
cells	NULL
was	NULL
abolished	NULL
by	NULL
the	NULL
antiserum	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
pre-immune	NULL
serum	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
protein-DNA	NULL
complex	NULL
of	NULL
NF-xB	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

c-rel	NULL
is	NULL
another	NULL
protein	NULL
which	NULL
can	NULL
recognize	NULL
xB	NULL
sequence	NULL
motifs	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
and	NULL
shares	NULL
high	NULL
homology	NULL
with	NULL
p50	NULL
NF-xB	NULL
within	NULL
a	NULL
300	NULL
amino	NULL
acid	NULL
long	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domain	NULL
(	NULL
Bours	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

An	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
unique	NULL
C-terminus	NULL
of	NULL
the	NULL
human	NULL
c-rel	NULL
protein	NULL
(	NULL
Brownell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
did	NULL
not	NULL
react	NULL
with	NULL
the	NULL
purified	NULL
NF-xB	NULL
and	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
-activated	NULL
factor	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

All	NULL
three	NULL
sera	NULL
contained	NULL
a	NULL
factor	NULL
which	NULL
gave	NULL
rise	NULL
to	NULL
a	NULL
very	NULL
slowly	NULL
migrating	NULL
protein-DNA	NULL
complex	NULL
in	NULL
EMSAs	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lanes	NULL
3-11	NULL
)	NULL
and	NULL
was	NULL
present	NULL
in	NULL
different	NULL
amounts	NULL
in	NULL
the	NULL
sera	NULL
(	NULL
lanes	NULL
9-11	NULL
)	NULL
.	NULL

A	NULL
characteristic	NULL
of	NULL
NF-xB	NULL
is	NULL
its	NULL
activation	NULL
by	NULL
a	NULL
post-translational	NULL
mechanism	NULL
involving	NULL
the	NULL
release	NULL
of	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
from	NULL
a	NULL
latent	NULL
cytoplasmic	NULL
form	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988a	NULL
,	NULL
b	NULL
;	NULL
for	NULL
a	NULL
review	NULL
see	NULL
Bacuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
was	NULL
a	NULL
post-translational	NULL
event	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

If	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
or	NULL
50	NULL
ug/ml	NULL
cycloheximide	NULL
alone	NULL
,	NULL
a	NULL
weak	NULL
activation	NULL
of	NULL
NF-xB	NULL
was	NULL
seen	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

A	NULL
treatment	NULL
with	NULL
50	NULL
uM	NULL
H	NULL
,	NULL
O	NULL
;	NULL
for	NULL
2	NULL
h	NULL
was	NULL
chosen	NULL
to	NULL
obtain	NULL
only	NULL
a	NULL
sub-optimal	NULL
activation	NULL
of	NULL
NF-xB	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ug/ml	NULL
cycloheximide	NULL
,	NULL
the	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
could	NULL
further	NULL
increase	NULL
the	NULL
amount	NULL
of	NULL
nuclear	NULL
NF-xB	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

As	NULL
determined	NULL
by	NULL
Cerenkov	NULL
counting	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
and	NULL
H	NULL
;	NULL
O	NULL
;	NULL
were	NULL
additive	NULL
.	NULL

In	NULL
a	NULL
combined	NULL
treatment	NULL
with	NULL
50	NULL
ug/ml	NULL
cycloheximide	NULL
and	NULL
50	NULL
«	NULL
M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
,	NULL
a	NULL
slight	NULL
superinduction	NULL
was	NULL
observed	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
occurred	NULL
post-translationally	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
oxidant	NULL
stress	NULL
is	NULL
specific	NULL
We	NULL
tested	NULL
whether	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
influences	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
other	NULL
inducible	NULL
and	NULL
constitutive	NULL
transcription	NULL
factors	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
from	NULL
control	NULL
and	NULL
H	NULL
;	NULL
O	NULL
;	NULL
-treated	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
P-labeled	NULL
DNA	NULL
probes	NULL
which	NULL
allow	NULL
detection	NULL
of	NULL
the	NULL
DNA-binding	NULL
activities	NULL
of	NULL
NF-xB	NULL
,	NULL
AP-l/c-fos	NULL
proteins	NULL
,	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
various	NULL
octamer-binding	NULL
proteins	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Johnson	NULL
and	NULL
McKnight	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
was	NULL
tested	NULL
by	NULL
competition	NULL
with	NULL
the	NULL
respective	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

An	NULL
induction	NULL
of	NULL
a	NULL
DNA-binding	NULL
activity	NULL
was	NULL
only	NULL
seen	NULL
with	NULL
the	NULL
xB	NULL
probe	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
first	NULL
panel	NULL
)	NULL
.	NULL

H	NULL
,	NULL
O	NULL
;	NULL
did	NULL
not	NULL
induce	NULL
activities	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
probe	NULL
or	NULL
a	NULL
glucocorticoid	NULL
response	NULL
element	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
panels	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
constitutive	NULL
DNA-binding	NULL
activities	NULL
of	NULL
the	NULL
ubiquitous	NULL
oct-1	NULL
and	NULL
faster-migrating	NULL
lymphoid-specific	NULL
oct-2	NULL
proteins	NULL
were	NULL
unchanged	NULL
after	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
last	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
2250	NULL
nd	NULL
bd	NULL
bt	NULL
bt	NULL
tnd	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
H	NULL
,	NULL
O	NULL
;	NULL
effect	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
an	NULL
H	NULL
,	NULL
O	NULL
,	NULL
treatment	NULL
on	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
other	NULL
inducible	NULL
and	NULL
constitutive	NULL
transcription	NULL
factors	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
control	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
7	NULL
and	NULL
10	NULL
)	NULL
and	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treated	NULL
Jurkat	NULL
cells	NULL
(	NULL
100	NULL
uM	NULL
;	NULL
3	NULL
h	NULL
)	NULL
were	NULL
reacted	NULL
with	NULL
*P-labeled	NULL
DNA	NULL
probes	NULL
detecting	NULL
NF-xB	NULL
(	NULL
xB	NULL
;	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
jun/c-fos	NULL
proteins	NULL
(	NULL
AP-1	NULL
;	NULL
lanes	NULL
4-5	NULL
)	NULL
,	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
;	NULL
lanes	NULL
7-9	NULL
)	NULL
and	NULL
octamer-binding	NULL
proteins	NULL
(	NULL
oct	NULL
;	NULL
lanes	NULL
10-12	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
and	NULL
12	NULL
,	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
respective	NULL
unlabeled	NULL
specific	NULL
oligonucleotide	NULL
was	NULL
added	NULL
as	NULL
competitor	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Fluorograms	NULL
of	NULL
native	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

Filled	NULL
arrowheads	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
presumably	NULL
specific	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

The	NULL
open	NULL
arrowhead	NULL
shows	NULL
the	NULL
position	NULL
of	NULL
the	NULL
unbound	NULL
DNA	NULL
probes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
effects	NULL
of	NULL
heat	NULL
shock	NULL
and	NULL
chemical	NULL
stress	NULL
factors	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
NF-xB	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
42°C	NULL
(	NULL
HS	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
for	NULL
4	NULL
h	NULL
with	NULL
50	NULL
4M	NULL
cadmium	NULL
sulfate	NULL
(	NULL
Cd	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
50	NULL
gM	NULL
sodium	NULL
arsenite	NULL
(	NULL
Ars	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
50	NULL
4M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
shows	NULL
control	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
labeled	NULL
x	NULL
enhancer	NULL
probe	NULL
.	NULL

A	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
filled	NULL
arrowhead	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-xB-DNA	NULL
complex	NULL
and	NULL
the	NULL
open	NULL
arrowhead	NULL
the	NULL
position	NULL
of	NULL
unbound	NULL
DNA	NULL
probe	NULL
.	NULL

H	NULL
,	NULL
O	NULL
,	NULL
appears	NULL
to	NULL
activate	NULL
specifically	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
.	NULL

Various	NULL
DNA-binding	NULL
activities	NULL
detected	NULL
with	NULL
other	NULL
DNA	NULL
probes	NULL
are	NULL
either	NULL
unchanged	NULL
or	NULL
show	NULL
a	NULL
slight	NULL
decrease	NULL
in	NULL
activity	NULL
which	NULL
might	NULL
be	NULL
indicative	NULL
of	NULL
some	NULL
oxidative	NULL
damage	NULL
.	NULL

Besides	NULL
oxidant	NULL
stress	NULL
,	NULL
also	NULL
heat	NULL
shock	NULL
and	NULL
chemical	NULL
inducers	NULL
of	NULL
the	NULL
cellular	NULL
stress	NULL
response	NULL
can	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
(	NULL
Ashburner	NULL
and	NULL
Bonner	NULL
,	NULL
1979	NULL
;	NULL
Ananthan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Zimarino	NULL
and	NULL
Wu	NULL
,	NULL
1987	NULL
;	NULL
Ciavarra	NULL
and	NULL
Simeone	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
whether	NULL
exposure	NULL
of	NULL
Jurkat	NULL
cells	NULL
to	NULL
heat	NULL
shock	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
cadmium	NULL
sulfate	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
sodium	NULL
arsenite	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
under	NULL
previously	NULL
reported	NULL
conditions	NULL
(	NULL
Geelen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
for	NULL
the	NULL
same	NULL
duration	NULL
as	NULL
the	NULL
H	NULL
,	NULL
O	NULL
,	NULL
treatment	NULL
(	NULL
1-4	NULL
h	NULL
)	NULL
can	NULL
activate	NULL
NF-xB	NULL
.	NULL

None	NULL
of	NULL
the	NULL
treatments	NULL
caused	NULL
a	NULL
rapid	NULL
appearance	NULL
of	NULL
detectable	NULL
amounts	NULL
of	NULL
NF-xB	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
NF-xB	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
which	NULL
is	NULL
specifically	NULL
activated	NULL
if	NULL
T	NULL
cells	NULL
are	NULL
exposed	NULL
to	NULL
oxidant	NULL
stress	NULL
.	NULL

Low	NULL
concentrations	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
induce	NULL
expression	NULL
of	NULL
HIV-1	NULL
In	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
NF-xB	NULL
binding	NULL
sites	NULL
in	NULL
promoters	NULL
and	NULL
enhancers	NULL
of	NULL
genes	NULL
serve	NULL
as	NULL
response	NULL
elements	NULL
that	NULL
confer	NULL
activation	NULL
of	NULL
genes	NULL
following	NULL
treatment	NULL
with	NULL
TNF-a	NULL
(	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Lowenthal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
TNF-8	NULL
(	NULL
Messer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Paul	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
PMA	NULL
and	NULL
lectins	NULL
(	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

In	NULL
the	NULL
following	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
tested	NULL
whether	NULL
the	NULL
NF-xB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
can	NULL
also	NULL
serve	NULL
as	NULL
response	NULL
elements	NULL
for	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
,	NULL
,	NULL
an	NULL
agent	NULL
produced	NULL
during	NULL
inflammatory	NULL
processes	NULL
by	NULL
granulocytes	NULL
and	NULL
macrophages	NULL
(	NULL
Figure	NULL
4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

A	NULL
reporter	NULL
gene	NULL
construct	NULL
with	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer/	NULL
promoter	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
either	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
the	NULL
lectin	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
,	NULL
10-50	NULL
LM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
,	NULL
or	NULL
with	NULL
human	NULL
TNF-a	NULL
.	NULL

Thereafter	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
extracts	NULL
assayed	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
product	NULL
,	NULL
the	NULL
CAT	NULL
enzyme	NULL
.	NULL

H	NULL
,	NULL
O	NULL
;	NULL
caused	NULL
a	NULL
strong	NULL
induction	NULL
of	NULL
CAT	NULL
enzyme	NULL
activity	NULL
as	NULL
was	NULL
evident	NULL
from	NULL
the	NULL
increased	NULL
acetylation	NULL
of	NULL
chloramphenicol	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
(	NULL
Figure	NULL
4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

While	NULL
10	NULL
uM	NULL
H	NULL
;	NULL
0	NULL
,	NULL
were	NULL
ineffective	NULL
,	NULL
30	NULL
uM	NULL
gave	NULL
a	NULL
maximal	NULL
induction	NULL
which	NULL
was	NULL
not	NULL
further	NULL
augmented	NULL
by	NULL
treatment	NULL
with	NULL
50	NULL
4M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

The	NULL
11-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
after	NULL
treatment	NULL
with	NULL
30	NULL
aM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
was	NULL
as	NULL
strong	NULL
as	NULL
that	NULL
obtained	NULL
with	NULL
PMA/PHA	NULL
treatment	NULL
and	NULL
even	NULL
higher	NULL
than	NULL
that	NULL
seen	NULL
after	NULL
treatment	NULL
with	NULL
TNF-a	NULL
(	NULL
seven-fold	NULL
induction	NULL
)	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
NF-xB-binding	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
,	NULL
-inducible	NULL
CAT	NULL
gene	NULL
expression	NULL
,	NULL
a	NULL
construct	NULL
was	NULL
used	NULL
in	NULL
which	NULL
the	NULL
two	NULL
xB	NULL
motifs	NULL
were	NULL
mutated	NULL
such	NULL
that	NULL
binding	NULL
of	NULL
NF-xB	NULL
is	NULL
abolished	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

This	NULL
xB	NULL
mutant	NULL
construct	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
showed	NULL
no	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
upon	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
,	NULL
PMA/PHA	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

The	NULL
dependence	NULL
of	NULL
the	NULL
gene	NULL
inducibility	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
a	NULL
TNF-a	NULL
and	NULL
PMA/PHA	NULL
treatment	NULL
on	NULL
intact	NULL
NF-xB-binding	NULL
sites	NULL
is	NULL
consistent	NULL
with	NULL
earlier	NULL
data	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Duh	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
increase	NULL
in	NULL
CAT	NULL
enzyme	NULL
activity	NULL
after	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
of	NULL
cells	NULL
was	NULL
completely	NULL
dependent	NULL
on	NULL
the	NULL
NF-xB	NULL
elements	NULL
in	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
,	NULL
it	NULL
is	NULL
very	NULL
unlikely	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
increased	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
CAT	NULL
mRNA	NULL
,	NULL
induced	NULL
an	NULL
endogenous	NULL
acetylation	NULL
activity	NULL
or	NULL
stimulated	NULL
the	NULL
basal	NULL
CAT	NULL
enzyme	NULL
activity	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
data	NULL
show	NULL
that	NULL
«	NULL
M-concentrations	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
can	NULL
potently	NULL
activate	NULL
HIV-1	NULL
LTR-controlled	NULL
gene	NULL
expression	NULL
depending	NULL
on	NULL
the	NULL
two	NULL
NF-xB	NULL
binding	NULL
motifs	NULL
in	NULL
the	NULL
LTR	NULL
.	NULL

Activation	NULL
of	NULL
NF-xB	NULL
by	NULL
oxidant	NULL
stress	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
an	NULL
H	NULL
,	NULL
O	NULL
,	NULL
treatment	NULL
in	NULL
Jurkat	NULL
cells	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
HIV-1	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
on	NULL
the	NULL
HIV-1	NULL
LTR-controlled	NULL
expression	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
construct	NULL
controlled	NULL
by	NULL
the	NULL
promoter/enhancer	NULL
of	NULL
HIV-1	NULL
(	NULL
HIV-LTR	NULL
wt	NULL
)	NULL
or	NULL
a	NULL
construct	NULL
with	NULL
mutations	NULL
altering	NULL
the	NULL
two	NULL
NF-xB-binding	NULL
sites	NULL
in	NULL
the	NULL
LTR	NULL
(	NULL
HIV-LTR	NULL
xB	NULL
mu	NULL
)	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
the	NULL
last	NULL
position	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
a	NULL
mock	NULL
transfection	NULL
is	NULL
shown	NULL
.	NULL

Cells	NULL
transfected	NULL
by	NULL
the	NULL
DEAE	NULL
-dextran	NULL
method	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
Co	NULL
)	NULL
or	NULL
incubated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
lectin	NULL
phytohemagluttinin	NULL
(	NULL
PHA	NULL
)	NULL
,	NULL
10	NULL
,	NULL
30	NULL
or	NULL
50	NULL
1M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
or	NULL
recombinant	NULL
human	NULL
TNF-	NULL
.	NULL

The	NULL
acetylated	NULL
forms	NULL
of	NULL
[	NULL
'*C	NULL
)	NULL
chloramphenicol	NULL
(	NULL
Ac	NULL
)	NULL
were	NULL
separated	NULL
from	NULL
unreacted	NULL
reagent	NULL
(	NULL
Non-Ac	NULL
)	NULL
by	NULL
ascending	NULL
thin	NULL
layer	NULL
chromatography	NULL
.	NULL

An	NULL
autoradiogram	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantification	NULL
of	NULL
the	NULL
CAT	NULL
activity	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Bars	NULL
indicate	NULL
the	NULL
-fold	NULL
stimulation	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
comparison	NULL
with	NULL
untreated	NULL
cells	NULL
(	NULL
Co	NULL
;	NULL
set	NULL
to	NULL
1.0	NULL
)	NULL
.	NULL

Results	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
as	NULL
average	NULL
values	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
on	NULL
the	NULL
production	NULL
of	NULL
HIV-1	NULL
in	NULL
latently	NULL
infected	NULL
Jurkat	NULL
cells	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
inoculated	NULL
with	NULL
an	NULL
HIV-1	NULL
isolate	NULL
and	NULL
cultured	NULL
for	NULL
8	NULL
days	NULL
.	NULL

Washed	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
50	NULL
+M	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
,	NULL
.	NULL

50	NULL
ng/ml	NULL
PMA	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
Co	NULL
)	NULL
followed	NULL
by	NULL
determination	NULL
of	NULL
the	NULL
viral	NULL
p24	NULL
protein	NULL
in	NULL
culture	NULL
supernatants	NULL
by	NULL
ELISA	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
syncytia	NULL
by	NULL
a	NULL
titration	NULL
assay	NULL
(	NULL
SIA	NULL
)	NULL
.	NULL

2251	NULL
R.Schreck	NULL
,	NULL
P.Rieber	NULL
and	NULL
P.A.Baeuerle	NULL
We	NULL
next	NULL
tested	NULL
whether	NULL
treatment	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
can	NULL
activate	NULL
HIV-1	NULL
replication	NULL
in	NULL
latently	NULL
HIV-1	NULL
infected	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Infected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
50	NULL
gM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
50	NULL
ng/ml	NULL
PMA	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

Twenty-four	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
production	NULL
of	NULL
the	NULL
p24	NULL
protein	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
and	NULL
the	NULL
formation	NULL
of	NULL
syncytia	NULL
was	NULL
determined	NULL
in	NULL
a	NULL
titration	NULL
assay	NULL
using	NULL
C8166	NULL
cells	NULL
.	NULL

Untreated	NULL
cells	NULL
exhibited	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
p24	NULL
production	NULL
and	NULL
their	NULL
cell	NULL
culture	NULL
supernatants	NULL
caused	NULL
induction	NULL
of	NULL
syncytia	NULL
only	NULL
at	NULL
a	NULL
low	NULL
dilution	NULL
(	NULL
Figure	NULL
4C	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
50	NULL
uM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
caused	NULL
a	NULL
6.4-fold	NULL
increase	NULL
in	NULL
the	NULL
production	NULL
of	NULL
the	NULL
viral	NULL
p24	NULL
protein	NULL
and	NULL
the	NULL
cell	NULL
culture	NULL
supernatants	NULL
from	NULL
treated	NULL
cells	NULL
could	NULL
induce	NULL
the	NULL
formation	NULL
of	NULL
syncytia	NULL
at	NULL
a	NULL
100-fold	NULL
lower	NULL
dilution	NULL
than	NULL
culture	NULL
supernatants	NULL
from	NULL
control	NULL
cells	NULL
(	NULL
Figure	NULL
4C	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
PMA	NULL
showed	NULL
effects	NULL
very	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
H	NULL
;	NULL
,0O	NULL
;	NULL
,	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
and	NULL
viral	NULL
replication	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
H	NULL
,	NULL
O	NULL
;	NULL
might	NULL
be	NULL
of	NULL
great	NULL
significance	NULL
in	NULL
the	NULL
onset	NULL
of	NULL
HIV-1	NULL
production	NULL
in	NULL
AIDS	NULL
patients	NULL
that	NULL
suffer	NULL
from	NULL
secondary	NULL
infections	NULL
and	NULL
inflammatory	NULL
processes	NULL
.	NULL

NAC	NULL
blocks	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
NAC	NULL
can	NULL
raise	NULL
intracellular	NULL
GSH	NULL
levels	NULL
and	NULL
thereby	NULL
protect	NULL
cells	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
ROI	NULL
(	NULL
Aruoma	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
SH	NULL
group	NULL
of	NULL
the	NULL
agent	NULL
can	NULL
directly	NULL
react	NULL
with	NULL
radicals	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
tested	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
sensitive	NULL
to	NULL
NAC	NULL
which	NULL
would	NULL
indicate	NULL
an	NULL
involvement	NULL
of	NULL
oxygen	NULL
radicals	NULL
.	NULL

Cells	NULL
were	NULL
pre-incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
20	NULL
mM	NULL
NAC	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
and	NULL
6	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
treatment	NULL
with	NULL
50	NULL
or	NULL
100	NULL
gM	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
lanes	NULL
3-6	NULL
)	NULL
.	NULL

As	NULL
is	NULL
seen	NULL
in	NULL
a	NULL
fluorogram	NULL
(	NULL
Figure	NULL
SA	NULL
)	NULL
and	NULL
after	NULL
Cerenkov	NULL
counting	NULL
of	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
NAC	NULL
reduced	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
binding	NULL
after	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
by	NULL
~70	NULL
%	NULL
.	NULL

NAC	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
30	NULL
mM	NULL
showed	NULL
an	NULL
inhibition	NULL
of	NULL
90	NULL
%	NULL
(	NULL
see	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

NAC	NULL
did	NULL
not	NULL
have	NULL
an	NULL
inhibitory	NULL
effect	NULL
on	NULL
two	NULL
endogenous	NULL
non-specific	NULL
DNA-binding	NULL
activities	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
millimolar	NULL
amounts	NULL
of	NULL
NAC	NULL
(	NULL
sodium	NULL
form	NULL
)	NULL
simply	NULL
blocked	NULL
the	NULL
DNA-binding	NULL
of	NULL
NF-xB	NULL
in	NULL
the	NULL
assay	NULL
system	NULL
,	NULL
we	NULL
incubated	NULL
purified	NULL
NF-xB	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
NAC	NULL
(	NULL
Figure	NULL
5B	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
adjusted	NULL
to	NULL
the	NULL
same	NULL
Na+	NULL
concentration	NULL
because	NULL
sodium	NULL
ions	NULL
had	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
influence	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-xB	NULL
(	NULL
Zabel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Even	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
100	NULL
mM	NULL
NAC	NULL
,	NULL
no	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
NF-xB-DNA	NULL
complex	NULL
was	NULL
found	NULL
(	NULL
Figure	NULL
5B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
when	NULL
NAC	NULL
was	NULL
added	NULL
to	NULL
cells	NULL
at	NULL
the	NULL
end	NULL
of	NULL
an	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
,	NULL
no	NULL
inhibition	NULL
was	NULL
observed	NULL
(	NULL
Figure	NULL
5C	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Since	NULL
NAC	NULL
can	NULL
only	NULL
react	NULL
very	NULL
slowly	NULL
,	NULL
if	NULL
at	NULL
all	NULL
,	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
Aruoma	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
NAC	NULL
exerts	NULL
its	NULL
inhibitory	NULL
effect	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
primarily	NULL
within	NULL
intact	NULL
cells	NULL
by	NULL
elevating	NULL
GSH	NULL
levels	NULL
and/or	NULL
by	NULL
directly	NULL
reacting	NULL
with	NULL
a	NULL
metabolite	NULL
of	NULL
H	NULL
;	NULL
,	NULL
O0	NULL
;	NULL
.	NULL

Also	NULL
other	NULL
thiol	NULL
compounds	NULL
,	NULL
such	NULL
as	NULL
2-mercaptoethanol	NULL
,	NULL
dithiocarbamate	NULL
,	NULL
glutathione	NULL
or	NULL
disulfiram	NULL
at	NULL
concentrations	NULL
in	NULL
the	NULL
micromolar	NULL
to	NULL
millimolar	NULL
range	NULL
potently	NULL
blocked	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
(	NULL
R.Schreck	NULL
and	NULL
P.Bacuerle	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
NF-xB	NULL
is	NULL
activated	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
in	NULL
a	NULL
cell	NULL
free	NULL
system	NULL
(	NULL
Figure	NULL
5D	NULL
)	NULL
.	NULL

NF-xB	NULL
,	NULL
NF-xB-IxB	NULL
complex	NULL
and	NULL
a	NULL
cytosolic	NULL
fraction	NULL
and	NULL
nuclear	NULL
extract	NULL
from	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
100	NULL
4M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
intact	NULL
cells	NULL
,	NULL
no	NULL
induction	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
2252	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
in	NULL
vivo	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
20	NULL
mM	NULL
NAC	NULL
(	NULL
sodium	NULL
form	NULL
)	NULL
followed	NULL
by	NULL
a	NULL
one	NULL
hour	NULL
treatment	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
50	NULL
uM	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
or	NULL
100	NULL
aM	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Lanes	NULL
3	NULL
and	NULL
4	NULL
show	NULL
a	NULL
treatment	NULL
with	NULL
50	NULL
and	NULL
100	NULL
uM	NULL
H	NULL
,	NULL
O	NULL
;	NULL
alone	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
x	NULL
enhancer	NULL
probe	NULL
.	NULL

A	NULL
fluorogram	NULL
of	NULL
a	NULL
native	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
filled	NULL
arrowhead	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-xB-DNA	NULL
complex	NULL
,	NULL
the	NULL
open	NULL
arrowhead	NULL
the	NULL
position	NULL
of	NULL
the	NULL
unbound	NULL
DNA	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-xB	NULL
.	NULL

Purified	NULL
NF-xB	NULL
was	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
the	NULL
sodium	NULL
form	NULL
of	NULL
NAC	NULL
.	NULL

By	NULL
the	NULL
addition	NULL
of	NULL
NaCl	NULL
,	NULL
all	NULL
samples	NULL
were	NULL
adjusted	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
mM	NULL
sodium	NULL
.	NULL

A	NULL
binding	NULL
reaction	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NaCl	NULL
or	NULL
NAC	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
addition	NULL
of	NULL
NAC	NULL
at	NULL
the	NULL
end	NULL
of	NULL
a	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
.	NULL

After	NULL
a	NULL
1	NULL
h	NULL
incubation	NULL
with	NULL
100	NULL
aM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
NAC	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
in	NULL
vitro	NULL
on	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
active	NULL
NF-xB	NULL
and	NULL
its	NULL
latent	NULL
cytoplasmic	NULL
form	NULL
.	NULL

Purified	NULL
NF-xB	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
purified	NULL
NF-xB-IxB	NULL
complex	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
cytosol	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
from	NULL
control	NULL
Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
1M	NULL
H	NULL
,	NULL
O	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
followed	NULL
by	NULL
a	NULL
DNA-binding	NULL
reaction	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
on	NULL
native	NULL
gels	NULL
.	NULL

A	NULL
fluorogram	NULL
is	NULL
shown	NULL
.	NULL

of	NULL
NF-xB	NULL
was	NULL
observed	NULL
,	NULL
suggesting	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
can	NULL
not	NULL
directly	NULL
inactivate	NULL
and	NULL
release	NULL
IxB	NULL
from	NULL
NF-xB	NULL
(	NULL
Figure	NULL
5D	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
of	NULL
active	NULL
NF-xB	NULL
was	NULL
also	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
five	NULL
different	NULL
agents	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
human	NULL
TNF-a	NULL
(	NULL
13	NULL
ng/ml	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
100	NULL
uM	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
,	NULL
poly	NULL
(	NULL
rl	NULL
)	NULL
-poly	NULL
(	NULL
rC	NULL
)	NULL
(	NULL
r'rC	NULL
,	NULL
0.1	NULL
mg/ml	NULL
;	NULL
lanes	NULL
10	NULL
and	NULL
13	NULL
)	NULL
or	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
,	NULL
50	NULL
pg/ml	NULL
;	NULL
lanes	NULL
11	NULL
and	NULL
14	NULL
)	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1-4	NULL
and	NULL
9-11	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
30	NULL
mM	NULL
NAC	NULL
added	NULL
1	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
activating	NULL
treatment	NULL
(	NULL
lanes	NULL
5-8	NULL
and	NULL
12-14	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
labeled	NULL
x	NULL
enhancer	NULL
probe	NULL
.	NULL

Fluorograms	NULL
from	NULL
two	NULL
native	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
filled	NULL
arrowhead	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
NF-xB-DNA	NULL
complex	NULL
and	NULL
the	NULL
open	NULL
arrowhead	NULL
the	NULL
position	NULL
of	NULL
unbound	NULL
DNA	NULL
probe	NULL
.	NULL

not	NULL
influenced	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
(	NULL
Figure	NULL
5D	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
lends	NULL
further	NULL
support	NULL
to	NULL
the	NULL
idea	NULL
that	NULL
a	NULL
metabolite	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
NF-xB	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
AP-1	NULL
factor	NULL
by	NULL
PMA	NULL
appears	NULL
not	NULL
to	NULL
depend	NULL
on	NULL
ROI	NULL
because	NULL
the	NULL
presence	NULL
of	NULL
NAC	NULL
did	NULL
not	NULL
effect	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
DNA-binding	NULL
following	NULL
a	NULL
PMA	NULL
treatment	NULL
of	NULL
cells	NULL
(	NULL
R.Schreck	NULL
and	NULL
P.Baeuerle	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

This	NULL
also	NULL
suggests	NULL
that	NULL
NAC	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
PKC	NULL
.	NULL

Thiol	NULL
compounds	NULL
block	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
many	NULL
different	NULL
agents	NULL
Different	NULL
agents	NULL
are	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-xB	NULL
.	NULL

Among	NULL
them	NULL
are	NULL
TNF-a	NULL
(	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Lowenthal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
,	NULL
double-stranded	NULL
RNA	NULL
(	NULL
Lenardo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Visvanathan	NULL
and	NULL
Goodbourn	NULL
,	NULL
1989	NULL
)	NULL
,	NULL
cycloheximide	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
and	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
.	NULL

These	NULL
agents	NULL
are	NULL
thought	NULL
to	NULL
act	NULL
intracellularly	NULL
by	NULL
distinct	NULL
signalling	NULL
pathways	NULL
.	NULL

TNF-	NULL
was	NULL
shown	NULL
to	NULL
activate	NULL
NF-xB	NULL
independently	NULL
of	NULL
PKC	NULL
(	NULL
Meichle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
while	NULL
PMA	NULL
is	NULL
thought	NULL
to	NULL
inactivate	NULL
NF-xB	NULL
by	NULL
PKC	NULL
which	NULL
can	NULL
phosphorylate	NULL
and	NULL
subsequently	NULL
release	NULL
IxB	NULL
(	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Double-stranded	NULL
RNA	NULL
could	NULL
act	NULL
via	NULL
the	NULL
dI	NULL
kinase	NULL
(	NULL
for	NULL
review	NULL
see	NULL
London	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
and	NULL
cycloheximide	NULL
by	NULL
preventing	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
labile	NULL
inhibitor	NULL
of	NULL
NF-xB	NULL
activation	NULL
.	NULL

Finally	NULL
,	NULL
H	NULL
,	NULL
O	NULL
;	NULL
seems	NULL
to	NULL
act	NULL
via	NULL
ROI	NULL
as	NULL
supported	NULL
by	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
induction	NULL
towards	NULL
NAC	NULL
.	NULL

However	NULL
,	NULL
NAC	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
also	NULL
inhibit	NULL
HIV-1	NULL
replication	NULL
and	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
following	NULL
TNF-a	NULL
or	NULL
PMA	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
Roederer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
NAC	NULL
was	NULL
mediated	NULL
by	NULL
the	NULL
NF-xB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
of	NULL
NF-xB	NULL
by	NULL
TNF	NULL
Activation	NULL
of	NULL
NF-xB	NULL
by	NULL
oxidant	NULL
stress	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
two	NULL
different	NULL
thiol	NULL
compounds	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
different	NULL
agents	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

NF-x	NULL
activating	NULL
Cell	NULL
lines	NULL
Inhibition	NULL
by	NULL
-	NULL
Inhibition	NULL
by	NULL
agent	NULL
tested	NULL
30	NULL
mM	NULL
NAC	NULL
0.1	NULL
mM	NULL
PDTC	NULL
H	NULL
,	NULL
O	NULL
;	NULL
Jurkat	NULL
++++	NULL
n.d.	NULL
Ltk~	NULL
++++	NULL
n.d.	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
Jurkat	NULL
+++	NULL
+4	NULL
++++	NULL
702/73	NULL
n.d.	NULL
++++	NULL
Ltk~	NULL
n.d.	NULL
++++	NULL
Interleukin-	NULL
1	NULL
70273	NULL
+++	NULL
+++	NULL
Ltk=	NULL
+++	NULL
n.d.	NULL
Double-stranded	NULL
RNA	NULL
-	NULL
Jurkat	NULL
++++	NULL
n.d.	NULL
Lipopolysaccharide	NULL
70273	NULL
+++	NULL
++++	NULL
PMA	NULL
Jurkat	NULL
+++	NULL
+4	NULL
++++	NULL
702/3	NULL
+++	NULL
++++	NULL
Ltk~	NULL
n.d.	NULL
++++	NULL
PMA	NULL
+	NULL
lectin	NULL
Jurkat	NULL
++++	NULL
++++	NULL
Cycloheximide	NULL
Jurkat	NULL
+++	NULL
n.d.	NULL
Calcium	NULL
ionophore	NULL
Jurkat	NULL
++++	NULL
n.d.	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
Ltk~	NULL
)	NULL
and	NULL
mouse	NULL
pre-B	NULL
cells	NULL
(	NULL
70Z/3	NULL
)	NULL
were	NULL
treated	NULL
as	NULL
indicated	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
100	NULL
aM	NULL
;	NULL
2	NULL
h	NULL
)	NULL
,	NULL
human	NULL
recombinant	NULL
TNF-a	NULL
(	NULL
13	NULL
ng/ml	NULL
;	NULL
1-3	NULL
h	NULL
)	NULL
,	NULL
human	NULL
recombinant	NULL
IL-1	NULL
(	NULL
10	NULL
U/ml	NULL
;	NULL
1-2	NULL
h	NULL
)	NULL
,	NULL
double-stranded	NULL
RNA	NULL
[	NULL
poly	NULL
(	NULL
rl	NULL
)	NULL
-poly	NULL
(	NULL
rC	NULL
)	NULL
;	NULL
4	NULL
h	NULL
]	NULL
,	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
;	NULL
1-3	NULL
h	NULL
)	NULL
,	NULL
PMA	NULL
plus	NULL
lectin	NULL
(	NULL
5	NULL
ug/ml	NULL
PHA	NULL
;	NULL
2	NULL
h	NULL
)	NULL
,	NULL
cycloheximide	NULL
(	NULL
10	NULL
ug/ml	NULL
;	NULL
3	NULL
h	NULL
)	NULL
or	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
(	NULL
1	NULL
aM	NULL
;	NULL
3	NULL
h	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
30	NULL
mM	NULL
NAC	NULL
or	NULL
0.1	NULL
mM	NULL
PDTC	NULL
added	NULL
|	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
activating	NULL
agents	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
and	NULL
the	NULL
protein-DNA	NULL
complex	NULL
of	NULL
NF-xB	NULL
quantified	NULL
by	NULL
Cerenkov	NULL
counting	NULL
.	NULL

+++	NULL
,	NULL
50-75	NULL
%	NULL
inhibition	NULL
;	NULL
+++	NULL
+	NULL
,	NULL
75-100	NULL
%	NULL
inhibition	NULL
``	NULL
Also	NULL
reported	NULL
by	NULL
Staal	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
;	NULL
n.d.	NULL
,	NULL
not	NULL
determined	NULL
«	NULL
and	NULL
PMA	NULL
is	NULL
decreased	NULL
by	NULL
the	NULL
compound	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
the	NULL
following	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
by	NULL
five	NULL
distinct	NULL
agents	NULL
is	NULL
inhibited	NULL
in	NULL
each	NULL
case	NULL
by	NULL
NAC	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
30	NULL
mM	NULL
NAC	NULL
with	NULL
the	NULL
following	NULL
compounds	NULL
:	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
(	NULL
Figure	NULL
6	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
human	NULL
TNF-a	NULL
,	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
H	NULL
;	NULL
O	NULL
;	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
poly	NULL
(	NULL
rl	NULL
)	NULL
-poly	NULL
(	NULL
rC	NULL
)	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
and	NULL
cycloheximide	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
a	NULL
significant	NULL
accumulation	NULL
of	NULL
active	NULL
NF-xB	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
seen	NULL
.	NULL

PMA	NULL
and	NULL
cycloheximide	NULL
gave	NULL
the	NULL
weakest	NULL
induction	NULL
of	NULL
DNA-binding	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
NAC	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
by	NULL
all	NULL
five	NULL
agents	NULL
was	NULL
efficiently	NULL
blocked	NULL
(	NULL
Figure	NULL
6	NULL
,	NULL
lanes	NULL
6-8	NULL
,	NULL
13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
inhibition	NULL
by	NULL
NAC	NULL
was	NULL
very	NULL
similar	NULL
with	NULL
the	NULL
five	NULL
inducers	NULL
and	NULL
was	NULL
in	NULL
the	NULL
range	NULL
80-90	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
Cerenkov	NULL
counting	NULL
of	NULL
the	NULL
radioactivity	NULL
in	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

In	NULL
search	NULL
of	NULL
a	NULL
more	NULL
potent	NULL
inhibitor	NULL
of	NULL
NF-xB	NULL
,	NULL
we	NULL
tested	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
agents	NULL
mainly	NULL
encompassing	NULL
thiol	NULL
compounds	NULL
and	NULL
metal	NULL
chelators	NULL
(	NULL
R.	NULL
Schreck	NULL
and	NULL
P.	NULL
Baeuerle	NULL
,	NULL
to	NULL
be	NULL
published	NULL
elsewhere	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
agents	NULL
showed	NULL
inhibitory	NULL
effects	NULL
but	NULL
at	NULL
very	NULL
different	NULL
concentrations	NULL
.	NULL

One	NULL
of	NULL
the	NULL
most	NULL
potent	NULL
and	NULL
specific	NULL
agents	NULL
was	NULL
a	NULL
pyrrolidone	NULL
derivative	NULL
of	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
.	NULL

In	NULL
Table	NULL
I	NULL
,	NULL
we	NULL
compare	NULL
the	NULL
effects	NULL
of	NULL
30	NULL
mM	NULL
NAC	NULL
and	NULL
0.1	NULL
mM	NULL
PDTC	NULL
on	NULL
the	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
induction	NULL
by	NULL
the	NULL
five	NULL
agents	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
and	NULL
by	NULL
four	NULL
other	NULL
agents	NULL
known	NULL
to	NULL
activate	NULL
NF-xB	NULL
.	NULL

These	NULL
other	NULL
agents	NULL
were	NULL
LPS	NULL
,	NULL
which	NULL
is	NULL
a	NULL
strong	NULL
inducer	NULL
of	NULL
NF-xB	NULL
in	NULL
the	NULL
pre-B	NULL
cell	NULL
line	NULL
70Z/3	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
)	NULL
,	NULL
IL-1	NULL
,	NULL
which	NULL
can	NULL
activate	NULL
NF-xB	NULL
in	NULL
702/3	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
and	NULL
the	NULL
lectin	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
which	NULL
activate	NULL
NF-xB	NULL
in	NULL
T	NULL
cells	NULL
strongly	NULL
when	NULL
in	NULL
2253	NULL
R.Schreck	NULL
,	NULL
P.Rieber	NULL
and	NULL
P.A.Baeuerle	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

A	NULL
model	NULL
showing	NULL
the	NULL
presumed	NULL
involvement	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

combination	NULL
with	NULL
PMA	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
)	NULL
but	NULL
only	NULL
weakly	NULL
if	NULL
applied	NULL
on	NULL
their	NULL
own	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
.	NULL

First	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
NF-xB	NULL
by	NULL
NAC	NULL
and	NULL
PDTC	NULL
was	NULL
not	NULL
restricted	NULL
to	NULL
Jurkat	NULL
cells	NULL
but	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
a	NULL
mouse	NULL
fibroblast	NULL
line	NULL
(	NULL
Ltk=	NULL
)	NULL
and	NULL
a	NULL
mouse	NULL
pre-B	NULL
cell	NULL
line	NULL
(	NULL
70Z/3	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
both	NULL
thiol	NULL
agents	NULL
,	NULL
though	NULL
chemically	NULL
distinct	NULL
,	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
binding	NULL
activity	NULL
regardless	NULL
of	NULL
the	NULL
activating	NULL
agent	NULL
or	NULL
cell	NULL
line	NULL
tested	NULL
.	NULL

Third	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
by	NULL
LPS	NULL
,	NULL
IL-1	NULL
,	NULL
calcium	NULL
ionophore	NULL
and	NULL
PHA/PMA	NULL
was	NULL
also	NULL
efficiently	NULL
blocked	NULL
by	NULL
NAC	NULL
and/or	NULL
PDTC	NULL
.	NULL

These	NULL
result	NULL
suggests	NULL
that	NULL
PMA	NULL
,	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
,	NULL
LPS	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
cycloheximide	NULL
,	NULL
calcium	NULL
ionophore	NULL
,	NULL
lectin	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
might	NULL
all	NULL
activate	NULL
NF-xB	NULL
by	NULL
the	NULL
same	NULL
mechanism	NULL
involving	NULL
a	NULL
NAC/PDTC-sensitive	NULL
intracellular	NULL
signalling	NULL
step	NULL
.	NULL

The	NULL
common	NULL
messenger	NULL
which	NULL
is	NULL
sensitive	NULL
to	NULL
radical-scavenging	NULL
thiol	NULL
agents	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
reactive	NULL
oxygen	NULL
intermediate	NULL
.	NULL

A	NULL
model	NULL
summarizing	NULL
this	NULL
idea	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
.	NULL

Discussion	NULL
Treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
hydrogen	NULL
peroxide	NULL
induces	NULL
the	NULL
DNA-binding	NULL
and	NULL
nuclear	NULL
appearance	NULL
of	NULL
a	NULL
factor	NULL
.	NULL

Evidence	NULL
that	NULL
this	NULL
factor	NULL
is	NULL
NF-xB	NULL
includes	NULL
the	NULL
xB-specific	NULL
DNA-binding	NULL
,	NULL
the	NULL
co-migration	NULL
of	NULL
its	NULL
protein-DNA	NULL
complex	NULL
with	NULL
that	NULL
of	NULL
purified	NULL
NF-xB	NULL
,	NULL
its	NULL
immunoreactivity	NULL
with	NULL
antisera	NULL
raised	NULL
against	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
NF-xB	NULL
and	NULL
the	NULL
2254	NULL
post-translational	NULL
induction	NULL
of	NULL
its	NULL
DNA-binding	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
specific	NULL
event	NULL
because	NULL
(	NULL
i	NULL
)	NULL
it	NULL
occurs	NULL
at	NULL
low	NULL
extracellular	NULL
concentrations	NULL
of	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
,	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
unaffected	NULL
by	NULL
the	NULL
treatment	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
because	NULL
other	NULL
kinds	NULL
of	NULL
cellular	NULL
stress	NULL
do	NULL
not	NULL
induce	NULL
the	NULL
activity	NULL
of	NULL
NF-xB	NULL
under	NULL
the	NULL
conditions	NULL
tested	NULL
.	NULL

Addition	NULL
of	NULL
only	NULL
30	NULL
uM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
was	NULL
sufficient	NULL
to	NULL
transactivate	NULL
the	NULL
HIV-LTR	NULL
to	NULL
an	NULL
extent	NULL
seen	NULL
with	NULL
TNF-a	NULL
or	NULL
a	NULL
PMA/PHA	NULL
treatment	NULL
of	NULL
cells	NULL
.	NULL

It	NULL
should	NULL
however	NULL
,	NULL
be	NULL
considered	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
can	NULL
decompose	NULL
in	NULL
serum-containing	NULL
medium	NULL
;	NULL
within	NULL
one	NULL
hour	NULL
the	NULL
initial	NULL
H	NULL
,	NULL
O	NULL
;	NULL
concentration	NULL
was	NULL
found	NULL
to	NULL
decrease	NULL
by	NULL
60	NULL
%	NULL
(	NULL
Link	NULL
and	NULL
Riley	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

Enzymes	NULL
released	NULL
from	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
catalases	NULL
,	NULL
could	NULL
further	NULL
deplete	NULL
the	NULL
initial	NULL
amount	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
cultures	NULL
.	NULL

Presumably	NULL
,	NULL
the	NULL
actual	NULL
concentration	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
that	NULL
induced	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
HIV-1	NULL
in	NULL
cell	NULL
cultures	NULL
was	NULL
therefore	NULL
much	NULL
lower	NULL
than	NULL
the	NULL
theoretical	NULL
one	NULL
.	NULL

Another	NULL
important	NULL
criterion	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
H	NULL
,	NULL
O	NULL
;	NULL
effect	NULL
is	NULL
that	NULL
other	NULL
cellular	NULL
stress	NULL
reactions	NULL
such	NULL
as	NULL
heat	NULL
shock	NULL
and	NULL
chemicals	NULL
did	NULL
not	NULL
activate	NULL
NF-xB	NULL
.	NULL

Thus	NULL
,	NULL
xB	NULL
elements	NULL
in	NULL
regulatory	NULL
domains	NULL
of	NULL
genes	NULL
appear	NULL
to	NULL
serve	NULL
specifically	NULL
as	NULL
response	NULL
elements	NULL
for	NULL
oxidant	NULL
stress	NULL
but	NULL
not	NULL
for	NULL
other	NULL
types	NULL
of	NULL
cellular	NULL
stress	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
proposed	NULL
that	NULL
NF-xB	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
which	NULL
has	NULL
specialized	NULL
in	NULL
the	NULL
organism	NULL
to	NULL
induce	NULL
the	NULL
synthesis	NULL
of	NULL
defense	NULL
and	NULL
signalling	NULL
proteins	NULL
rapidly	NULL
upon	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
mostly	NULL
pathogenic	NULL
agents	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1991	NULL
;	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
present	NULL
findings	NULL
are	NULL
fully	NULL
consistent	NULL
with	NULL
this	NULL
idea	NULL
and	NULL
add	NULL
H	NULL
;	NULL
O	NULL
;	NULL
to	NULL
the	NULL
list	NULL
of	NULL
inducers	NULL
produced	NULL
under	NULL
pathogenic	NULL
conditions	NULL
.	NULL

In	NULL
liver	NULL
cells	NULL
,	NULL
measurements	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
normal	NULL
intracellular	NULL
concentration	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
is	NULL
in	NULL
the	NULL
sub-micromolar	NULL
range	NULL
whereas	NULL
other	NULL
tissues	NULL
such	NULL
as	NULL
the	NULL
eye	NULL
lens	NULL
reach	NULL
up	NULL
to	NULL
25	NULL
uM	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Halliwell	NULL
and	NULL
Gutteridge	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
blood	NULL
plasma	NULL
of	NULL
healthy	NULL
subjects	NULL
,	NULL
values	NULL
between	NULL
0.25	NULL
and	NULL
5	NULL
uM	NULL
were	NULL
determined	NULL
(	NULL
Frei	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

These	NULL
low	NULL
basal	NULL
levels	NULL
make	NULL
H	NULL
,	NULL
O	NULL
;	NULL
a	NULL
suitable	NULL
signal	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
when	NULL
there	NULL
is	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
extracellular	NULL
H	NULL
,	NULL
O	NULL
;	NULL
concentration	NULL
during	NULL
an	NULL
inflammatory	NULL
process	NULL
.	NULL

It	NULL
is	NULL
well	NULL
possible	NULL
that	NULL
the	NULL
local	NULL
H	NULL
,	NULL
O	NULL
,	NULL
concentrations	NULL
in	NULL
extracellular	NULL
fluids	NULL
during	NULL
inflammatory	NULL
processes	NULL
are	NULL
sufficient	NULL
to	NULL
activate	NULL
NF-xB	NULL
in	NULL
tissue	NULL
and	NULL
blood	NULL
cells	NULL
thereby	NULL
allowing	NULL
induction	NULL
of	NULL
the	NULL
synthesis	NULL
of	NULL
cytokines	NULL
,	NULL
immunologically	NULL
active	NULL
cell	NULL
surface	NULL
receptors	NULL
and	NULL
also	NULL
of	NULL
viruses	NULL
such	NULL
as	NULL
HIV-1	NULL
.	NULL

The	NULL
efficient	NULL
propagation	NULL
of	NULL
HIV-1	NULL
in	NULL
macrophages	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Meltzer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
might	NULL
be	NULL
related	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
effective	NULL
oxidative	NULL
bi	NULL
rst	NULL
machinery	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

There	NULL
is	NULL
an	NULL
overwhelmingly	NULL
la	NULL
ze	NULL
number	NULL
of	NULL
reports	NULL
dealing	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
oxygen	NULL
radicals	NULL
in	NULL
biological	NULL
and	NULL
pathobiological	NULL
systems	NULL
.	NULL

Future	NULL
studies	NULL
can	NULL
now	NULL
address	NULL
in	NULL
these	NULL
systems	NULL
the	NULL
role	NULL
of	NULL
NF-xB	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
which	NULL
is	NULL
specifically	NULL
activated	NULL
under	NULL
conditions	NULL
that	NULL
increase	NULL
the	NULL
intracellular	NULL
concentration	NULL
of	NULL
ROL	NULL
.	NULL

Possible	NULL
mechansims	NULL
of	NULL
H	NULL
;	NULL
,	NULL
O	NULL
,	NULL
-mediated	NULL
NF-xB	NULL
activation	NULL
A	NULL
central	NULL
event	NULL
in	NULL
the	NULL
post-translational	NULL
activation	NULL
of	NULL
NF-xB	NULL
is	NULL
the	NULL
release	NULL
of	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IxB	NULL
from	NULL
its	NULL
complex	NULL
with	NULL
p65	NULL
and	NULL
p50	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1991	NULL
;	NULL
Baeuerle	NULL
1991	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
IxB	NULL
allows	NULL
DNA-binding	NULL
of	NULL
NF-xB	NULL
and	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Any	NULL
reaction	NULL
that	NULL
abolishes	NULL
binding	NULL
of	NULL
IxB	NULL
to	NULL
p65	NULL
or	NULL
damages	NULL
IxB	NULL
should	NULL
thus	NULL
enable	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
on	NULL
its	NULL
own	NULL
is	NULL
unable	NULL
to	NULL
activate	NULL
the	NULL
purified	NULL
NF-xB-IxB	NULL
complex	NULL
or	NULL
that	NULL
contained	NULL
in	NULL
a	NULL
cytosolic	NULL
fraction	NULL
.	NULL

It	NULL
therefore	NULL
appears	NULL
that	NULL
a	NULL
metabolite	NULL
of	NULL
H	NULL
;	NULL
0	NULL
;	NULL
or	NULL
an	NULL
intracellular	NULL
reaction	NULL
induced	NULL
by	NULL
H	NULL
;	NULL
O	NULL
;	NULL
,	NULL
caused	NULL
the	NULL
release	NULL
of	NULL
IxB	NULL
.	NULL

After	NULL
its	NULL
passive	NULL
diffusion	NULL
through	NULL
the	NULL
cell	NULL
membrane	NULL
,	NULL
H	NULL
,	NULL
O	NULL
,	NULL
can	NULL
be	NULL
converted	NULL
into	NULL
more	NULL
reactive	NULL
oxygen	NULL
compounds	NULL
such	NULL
as	NULL
the	NULL
superoxide	NULL
anion	NULL
,	NULL
O	NULL
,	NULL
~	NULL
,	NULL
and	NULL
the	NULL
hydroxyl	NULL
radical	NULL
OH	NULL
:	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Halliwell	NULL
and	NULL
Gutteridge	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

While	NULL
OH	NULL
-	NULL
might	NULL
react	NULL
instantanously	NULL
with	NULL
any	NULL
macromolecule	NULL
,	NULL
O	NULL
,	NULL
~	NULL
is	NULL
less	NULL
reactive	NULL
and	NULL
can	NULL
diffuse	NULL
further	NULL
prior	NULL
to	NULL
a	NULL
reaction	NULL
.	NULL

An	NULL
involvement	NULL
of	NULL
radicals	NULL
in	NULL
the	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
-induced	NULL
activation	NULL
of	NULL
NF-xB	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
NAC	NULL
and	NULL
that	NULL
of	NULL
various	NULL
other	NULL
thiol	NULL
compounds	NULL
tested	NULL
(	NULL
R.Schreck	NULL
and	NULL
P.Baeuerle	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

NAC	NULL
raises	NULL
intracellular	NULL
GSH	NULL
levels	NULL
and	NULL
thereby	NULL
provides	NULL
GSH	NULL
peroxidase	NULL
with	NULL
the	NULL
co-substrate	NULL
required	NULL
to	NULL
eliminate	NULL
ROI	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Halliwell	NULL
and	NULL
Gutteridge	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NAC	NULL
can	NULL
directly	NULL
scavenge	NULL
radicals	NULL
(	NULL
Aruoma	NULL
etal	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
metal	NULL
chelators	NULL
desferroxamine	NULL
,	NULL
diethyldithiocarbamate	NULL
and	NULL
o-phenanthroline	NULL
also	NULL
blocked	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
R.Schreck	NULL
and	NULL
P.Baeuerle	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Metal	NULL
ions	NULL
such	NULL
as	NULL
Fe	NULL
*	NULL
are	NULL
required	NULL
for	NULL
the	NULL
interconversion	NULL
of	NULL
oxygen	NULL
radicals	NULL
.	NULL

Within	NULL
cells	NULL
,	NULL
oxygen	NULL
radicals	NULL
can	NULL
generate	NULL
other	NULL
reactive	NULL
substances	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
by	NULL
oxidizing	NULL
membrane	NULL
lipids	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Wolff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
Activation	NULL
of	NULL
NF-xB	NULL
by	NULL
oxidant	NULL
stress	NULL
whether	NULL
this	NULL
can	NULL
occur	NULL
to	NULL
a	NULL
relevant	NULL
extent	NULL
at	NULL
the	NULL
low	NULL
concentrations	NULL
of	NULL
H	NULL
,	NULL
O	NULL
,	NULL
used	NULL
here	NULL
to	NULL
activate	NULL
NF-xB	NULL
.	NULL

ROI	NULL
could	NULL
directly	NULL
activate	NULL
NF-xB	NULL
by	NULL
degrading	NULL
or	NULL
modifying	NULL
IxB	NULL
in	NULL
the	NULL
cytoplasmic	NULL
p50-p65-IxB	NULL
complex	NULL
.	NULL

The	NULL
oxidation	NULL
of	NULL
a	NULL
single	NULL
cysteine	NULL
residue	NULL
in	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
jun	NULL
and	NULL
fos	NULL
proteins	NULL
was	NULL
recently	NULL
found	NULL
to	NULL
allow	NULL
regulation	NULL
of	NULL
the	NULL
DNA-binding	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
in	NULL
vitro	NULL
(	NULL
Abate	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
reaction	NULL
could	NULL
selectively	NULL
inactivate	NULL
and	NULL
release	NULL
IxB	NULL
from	NULL
pSO-p65	NULL
.	NULL

A	NULL
frequently	NULL
observed	NULL
effect	NULL
of	NULL
oxidant	NULL
stress	NULL
is	NULL
also	NULL
the	NULL
induction	NULL
of	NULL
proteolysis	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Pacifici	NULL
and	NULL
Davies	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Oxidative	NULL
damage	NULL
or	NULL
a	NULL
controlled	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxB	NULL
would	NULL
both	NULL
provide	NULL
an	NULL
irreversible	NULL
mechansim	NULL
of	NULL
NF-xB	NULL
activation	NULL
.	NULL

This	NULL
idea	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
preliminary	NULL
observation	NULL
that	NULL
IxB	NULL
released	NULL
in	NULL
vivo	NULL
during	NULL
a	NULL
PMA	NULL
treatment	NULL
of	NULL
pre-B	NULL
cells	NULL
can	NULL
apparently	NULL
not	NULL
be	NULL
reused	NULL
to	NULL
inhibit	NULL
the	NULL
activated	NULL
NF-xB	NULL
(	NULL
Baeuerle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
understand	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
ROI	NULL
in	NULL
the	NULL
release	NULL
of	NULL
IxB	NULL
from	NULL
the	NULL
cytoplasmic	NULL
p50-p65-IxB	NULL
complex	NULL
.	NULL

Does	NULL
protein	NULL
kinase	NULL
C	NULL
directly	NULL
activate	NULL
NF-xB	NULL
in	NULL
vivo	NULL
?	NULL

The	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
PMA	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
radical	NULL
scavengers	NULL
NAC	NULL
and	NULL
PDTC	NULL
.	NULL

We	NULL
therefore	NULL
discuss	NULL
here	NULL
the	NULL
possibility	NULL
that	NULL
NF-xB	NULL
is	NULL
activated	NULL
by	NULL
ROI	NULL
produced	NULL
in	NULL
response	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
PKC	NULL
rather	NULL
than	NULL
directly	NULL
by	NULL
the	NULL
kinase	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
provided	NULL
evidence	NULL
for	NULL
a	NULL
direct	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
by	NULL
PKC	NULL
(	NULL
Shirakawa	NULL
and	NULL
Mizel	NULL
,	NULL
1989	NULL
;	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Using	NULL
highly	NULL
purified	NULL
components	NULL
,	NULL
we	NULL
obtained	NULL
the	NULL
same	NULL
results	NULL
(	NULL
E.Link	NULL
,	NULL
L.Kerr	NULL
,	NULL
R.Schreck	NULL
,	NULL
U.Zabel	NULL
,	NULL
I.	NULL
Vetma	NULL
and	NULL
P.Bauerle	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

There	NULL
is	NULL
,	NULL
however	NULL
,	NULL
also	NULL
a	NULL
series	NULL
of	NULL
observations	NULL
that	NULL
does	NULL
not	NULL
argue	NULL
in	NULL
favor	NULL
of	NULL
a	NULL
direct	NULL
mechanism	NULL
.	NULL

Ghosh	NULL
and	NULL
Baltimore	NULL
(	NULL
1990	NULL
)	NULL
only	NULL
observed	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
PKC	NULL
with	NULL
fractions	NULL
highly	NULL
enriched	NULL
for	NULL
p50-p65-IxB	NULL
but	NULL
not	NULL
with	NULL
crude	NULL
cytosol	NULL
.	NULL

Also	NULL
the	NULL
heme-regulated	NULL
kinase	NULL
and	NULL
the	NULL
cAMP-dependent	NULL
kinase	NULL
A	NULL
can	NULL
activate	NULL
NF-xB	NULL
in	NULL
vitro	NULL
although	NULL
there	NULL
is	NULL
no	NULL
conclusive	NULL
evidence	NULL
for	NULL
an	NULL
in	NULL
vivo	NULL
involvement	NULL
of	NULL
the	NULL
two	NULL
kinases	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

This	NULL
raises	NULL
doubts	NULL
about	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
PKC	NULL
reaction	NULL
.	NULL

In	NULL
HL-60	NULL
cells	NULL
,	NULL
TNF-a	NULL
can	NULL
rapidly	NULL
induce	NULL
PKC	NULL
but	NULL
the	NULL
NF-xB	NULL
activation	NULL
by	NULL
TNF-a	NULL
is	NULL
unchanged	NULL
when	NULL
PKC	NULL
was	NULL
depleted	NULL
by	NULL
chronic	NULL
PMA	NULL
treatment	NULL
or	NULL
inactivated	NULL
by	NULL
the	NULL
inhibitors	NULL
staurosporine	NULL
and	NULL
H-7	NULL
(	NULL
Schiitze	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Meichle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
PMA-induced	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
is	NULL
very	NULL
slow	NULL
compared	NULL
with	NULL
that	NULL
induced	NULL
by	NULL
TNF-	NULL
«	NULL
(	NULL
Hohmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

PKC	NULL
could	NULL
activate	NULL
NF-xB	NULL
by	NULL
directly	NULL
enhancing	NULL
the	NULL
activity	NULL
of	NULL
an	NULL
NADPH	NULL
oxidase-like	NULL
enzyme	NULL
.	NULL

These	NULL
enzymes	NULL
produce	NULL
superoxide	NULL
anions	NULL
and	NULL
H	NULL
,	NULL
O	NULL
,	NULL
from	NULL
O	NULL
;	NULL
,	NULL
and	NULL
NADPH	NULL
.	NULL

In	NULL
granulocytes	NULL
and	NULL
macrophages	NULL
,	NULL
PKC	NULL
can	NULL
activate	NULL
the	NULL
plasma-membrane	NULL
bound	NULL
NADPH	NULL
oxidase	NULL
within	NULL
seconds	NULL
after	NULL
PMA	NULL
stimulation	NULL
causing	NULL
the	NULL
oxidative	NULL
burst	NULL
reaction	NULL
(	NULL
Gennaro	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Christiansen	NULL
,	NULL
1988	NULL
;	NULL
Tauber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

PMA	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
superoxide	NULL
anions	NULL
not	NULL
only	NULL
in	NULL
granulocytes	NULL
and	NULL
macrophages	NULL
but	NULL
also	NULL
in	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
Rosen	NULL
and	NULL
Freeman	NULL
,	NULL
1984	NULL
;	NULL
Matsubara	NULL
and	NULL
Ziff	NULL
,	NULL
1986	NULL
;	NULL
Meier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Staal	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
observed	NULL
that	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
PMA	NULL
rapidly	NULL
decreased	NULL
intracellular	NULL
thiol	NULL
levels	NULL
,	NULL
supporting	NULL
the	NULL
idea	NULL
that	NULL
there	NULL
is	NULL
a	NULL
depletion	NULL
of	NULL
GSH	NULL
by	NULL
oxidants	NULL
.	NULL

Moreover	NULL
,	NULL
numerous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
tumor-promoting	NULL
effects	NULL
of	NULL
phorbol	NULL
esters	NULL
are	NULL
inhibited	NULL
by	NULL
antioxidants	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Cerutti	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

The	NULL
inhibitory	NULL
2255	NULL
R.Schreck	NULL
,	NULL
P.Rieber	NULL
and	NULL
P.A.Baeuerle	NULL
effect	NULL
of	NULL
the	NULL
antioxidant	NULL
NAC	NULL
and	NULL
PDTC	NULL
on	NULL
the	NULL
activation	NULL
by	NULL
PMA	NULL
of	NULL
NF-xB	NULL
but	NULL
not	NULL
of	NULL
AP-1	NULL
strongly	NULL
suggest	NULL
that	NULL
this	NULL
effect	NULL
of	NULL
the	NULL
phorbol	NULL
ester	NULL
treatment	NULL
also	NULL
relies	NULL
on	NULL
the	NULL
production	NULL
of	NULL
ROL	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
widely	NULL
used	NULL
second	NULL
messengers	NULL
While	NULL
there	NULL
is	NULL
good	NULL
evidence	NULL
that	NULL
PMA	NULL
can	NULL
exert	NULL
its	NULL
effects	NULL
on	NULL
gene	NULL
activity	NULL
by	NULL
interaction	NULL
with	NULL
its	NULL
receptor	NULL
PKC	NULL
,	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
used	NULL
by	NULL
TNF	NULL
is	NULL
not	NULL
known	NULL
and	NULL
apparently	NULL
does	NULL
not	NULL
require	NULL
PKC	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
(	NULL
Meichle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
PMA	NULL
and	NULL
TNF	NULL
both	NULL
activate	NULL
NF-xB	NULL
from	NULL
its	NULL
latent	NULL
cytoplasmic	NULL
form	NULL
and	NULL
share	NULL
xB	NULL
elements	NULL
as	NULL
enhancers	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
possibility	NULL
is	NULL
now	NULL
raised	NULL
that	NULL
the	NULL
two	NULL
agents	NULL
might	NULL
activate	NULL
NF-xB	NULL
by	NULL
a	NULL
common	NULL
pathway	NULL
diverging	NULL
upstream	NULL
of	NULL
IxB	NULL
and	NULL
involving	NULL
oxygen	NULL
radicals	NULL
.	NULL

Support	NULL
for	NULL
this	NULL
idea	NULL
includes	NULL
the	NULL
observations	NULL
that	NULL
,	NULL
(	NULL
i	NULL
)	NULL
both	NULL
PMA	NULL
and	NULL
TNF-a	NULL
stimulate	NULL
the	NULL
production	NULL
of	NULL
superoxide	NULL
anions	NULL
and	NULL
H	NULL
,	NULL
O	NULL
;	NULL
in	NULL
granulocytes	NULL
,	NULL
fibroblasts	NULL
and	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
Rosen	NULL
and	NULL
Freeman	NULL
,	NULL
1984	NULL
;	NULL
Matsubara	NULL
and	NULL
Ziff	NULL
,	NULL
1986	NULL
;	NULL
Klebanoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Meier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
)	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
both	NULL
agents	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
radical	NULL
scavenger	NULL
NAC	NULL
and	NULL
other	NULL
thiol	NULL
compounds	NULL
;	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
PMA	NULL
and	NULL
TNF	NULL
cause	NULL
a	NULL
rapid	NULL
depletion	NULL
of	NULL
the	NULL
GSH	NULL
levels	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

More	NULL
evidence	NULL
for	NULL
an	NULL
involvement	NULL
of	NULL
oxygen	NULL
radicals	NULL
in	NULL
TNF-a	NULL
«	NULL
effects	NULL
comes	NULL
from	NULL
experiments	NULL
using	NULL
oxygen	NULL
depletion	NULL
,	NULL
thiol	NULL
reagents	NULL
and	NULL
superoxide	NULL
dismutase	NULL
(	NULL
SOD	NULL
)	NULL
,	NULL
an	NULL
enzyme	NULL
eliminating	NULL
the	NULL
superoxide	NULL
anion	NULL
.	NULL

Anaerobic	NULL
conditions	NULL
(	NULL
Matthews	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
,	NULL
agents	NULL
elevating	NULL
GSH	NULL
levels	NULL
(	NULL
Zimmerman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
or	NULL
the	NULL
overexpression	NULL
of	NULL
SOD	NULL
(	NULL
Wong	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
desensitized	NULL
cells	NULL
for	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
TNF-a	NULL
.	NULL

At	NULL
present	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
to	NULL
what	NULL
extent	NULL
the	NULL
cytotoxicity	NULL
of	NULL
TNF	NULL
relies	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
(	NULL
for	NULL
a	NULL
recent	NULL
review	NULL
see	NULL
Larrick	NULL
and	NULL
Wright	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
tested	NULL
nine	NULL
conditions	NULL
that	NULL
were	NULL
reported	NULL
to	NULL
induce	NULL
NF-xB	NULL
and	NULL
,	NULL
without	NULL
any	NULL
exception	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
appeared	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
oxygen	NULL
radicals	NULL
.	NULL

Future	NULL
studies	NULL
have	NULL
to	NULL
address	NULL
the	NULL
generality	NULL
of	NULL
this	NULL
requirement	NULL
by	NULL
testing	NULL
other	NULL
conditions	NULL
under	NULL
which	NULL
NF-xB	NULL
is	NULL
induced	NULL
.	NULL

It	NULL
is	NULL
of	NULL
great	NULL
interest	NULL
to	NULL
see	NULL
whether	NULL
NAC	NULL
and	NULL
PDTC	NULL
inhibit	NULL
the	NULL
effect	NULL
of	NULL
UV	NULL
light	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
HIV-1	NULL
and	NULL
NF-xB	NULL
(	NULL
Valerie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Stein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
NF-xB-inducing	NULL
viral	NULL
transactivator	NULL
proteins	NULL
such	NULL
as	NULL
tax	NULL
(	NULL
Leung	NULL
and	NULL
Nabel	NULL
,	NULL
1988	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
,	NULL
X	NULL
(	NULL
Twu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
iel	NULL
(	NULL
Sambucetti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

There	NULL
are	NULL
many	NULL
ways	NULL
in	NULL
which	NULL
intracellular	NULL
levels	NULL
of	NULL
ROI	NULL
could	NULL
be	NULL
increased	NULL
.	NULL

One	NULL
is	NULL
to	NULL
inhibit	NULL
mechanisms	NULL
for	NULL
their	NULL
elimination	NULL
.	NULL

An	NULL
alternative	NULL
way	NULL
is	NULL
the	NULL
induction	NULL
of	NULL
enzymes	NULL
actively	NULL
producing	NULL
oxygen	NULL
radicals	NULL
.	NULL

Further	NULL
experiments	NULL
have	NULL
to	NULL
address	NULL
in	NULL
detail	NULL
the	NULL
origin	NULL
of	NULL
ROI	NULL
produced	NULL
in	NULL
response	NULL
to	NULL
inflammatory	NULL
cytokines	NULL
and	NULL
various	NULL
other	NULL
NF-xB	NULL
activating	NULL
agents	NULL
and	NULL
the	NULL
putative	NULL
role	NULL
of	NULL
ROI	NULL
in	NULL
signal	NULL
transduction	NULL
processes	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
form	NULL
of	NULL
the	NULL
NF-xB	NULL
transcription	NULL
factor	NULL
will	NULL
provide	NULL
a	NULL
valuable	NULL
monitoring	NULL
reaction	NULL
for	NULL
such	NULL
studies	NULL
.	NULL

A	NULL
role	NULL
of	NULL
radicals	NULL
as	NULL
second	NULL
messengers	NULL
is	NULL
not	NULL
without	NULL
precedent	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
nitric	NULL
oxide	NULL
radical	NULL
(	NULL
NO	NULL
)	NULL
such	NULL
a	NULL
role	NULL
is	NULL
now	NULL
becoming	NULL
widely	NULL
accepted	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Crossin	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

NO	NULL
stimulates	NULL
guanylate	NULL
cyclase	NULL
and	NULL
is	NULL
known	NULL
to	NULL
relax	NULL
vascular	NULL
smooth	NULL
muscle	NULL
and	NULL
to	NULL
modulate	NULL
messenger	NULL
pathways	NULL
in	NULL
the	NULL
developing	NULL
and	NULL
adult	NULL
brain	NULL
.	NULL

Does	NULL
it	NULL
make	NULL
sense	NULL
for	NULL
the	NULL
cell	NULL
to	NULL
engage	NULL
highly	NULL
toxic	NULL
2256	NULL
compounds	NULL
as	NULL
messenger	NULL
molecules	NULL
?	NULL

First	NULL
of	NULL
all	NULL
,	NULL
ROI	NULL
are	NULL
not	NULL
only	NULL
undesired	NULL
side	NULL
products	NULL
of	NULL
cellular	NULL
electron	NULL
transfer	NULL
reactions	NULL
but	NULL
there	NULL
are	NULL
ubiquitous	NULL
enzyme	NULL
systems	NULL
which	NULL
have	NULL
specialized	NULL
during	NULL
evolution	NULL
in	NULL
the	NULL
production	NULL
of	NULL
oxygen	NULL
radicals	NULL
and	NULL
H	NULL
,	NULL
O	NULL
.	NULL

Second	NULL
,	NULL
ROI	NULL
are	NULL
available	NULL
in	NULL
every	NULL
cell	NULL
type	NULL
,	NULL
either	NULL
from	NULL
intracellular	NULL
reactions	NULL
or	NULL
,	NULL
as	NULL
H	NULL
;	NULL
,	NULL
O	NULL
;	NULL
,	NULL
from	NULL
other	NULL
cells	NULL
.	NULL

Third	NULL
,	NULL
eukaryotic	NULL
cells	NULL
contain	NULL
multiple	NULL
enzymes	NULL
allowing	NULL
a	NULL
precise	NULL
and	NULL
rapid	NULL
regulation	NULL
of	NULL
intracellular	NULL
levels	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
,	NULL
among	NULL
them	NULL
superoxide	NULL
dismutase	NULL
,	NULL
the	NULL
GSH	NULL
peroxidase/GSH	NULL
system	NULL
,	NULL
catalase	NULL
and	NULL
peroxidases	NULL
.	NULL

Thus	NULL
,	NULL
ROI	NULL
fulfil	NULL
important	NULL
prerequisites	NULL
for	NULL
second	NULL
messenger	NULL
molecules	NULL
:	NULL
they	NULL
are	NULL
small	NULL
,	NULL
diffusible	NULL
and	NULL
ubiquitous	NULL
molecules	NULL
that	NULL
can	NULL
be	NULL
synthesized	NULL
and	NULL
destroyed	NULL
rapidly	NULL
.	NULL

However	NULL
,	NULL
there	NULL
might	NULL
be	NULL
only	NULL
a	NULL
narrow	NULL
concentration	NULL
range	NULL
in	NULL
which	NULL
they	NULL
can	NULL
function	NULL
exclusively	NULL
as	NULL
second	NULL
messengers	NULL
.	NULL

At	NULL
elevated	NULL
concentrations	NULL
,	NULL
ROI	NULL
serve	NULL
as	NULL
physiologically	NULL
important	NULL
cytotoxic	NULL
agents	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
Binding	NULL
conditions	NULL
for	NULL
NF-xB	NULL
were	NULL
characterized	NULL
and	NULL
EMSAs	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
(	NULL
Zabel	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
binding	NULL
reactions	NULL
(	NULL
20	NULL
gl	NULL
)	NULL
contained	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
5-10	NULL
000	NULL
c.p.m	NULL
.	NULL

(	NULL
Cerenkov	NULL
)	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
,	NULL
2	NULL
ul	NULL
buffer	NULL
D	NULL
(	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
containing	NULL
1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
ug	NULL
bovine	NULL
serum	NULL
albumin	NULL
and	NULL
binding	NULL
buffer	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
started	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
cell	NULL
extracts	NULL
or	NULL
purified	NULL
protein	NULL
and	NULL
allowed	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
on	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Cells	NULL
were	NULL
fractionated	NULL
into	NULL
cytoplasm	NULL
and	NULL
nuclei	NULL
,	NULL
and	NULL
cytosol	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988a	NULL
)	NULL
.	NULL

Equal	NULL
proportions	NULL
of	NULL
cell	NULL
fractions	NULL
with	NULL
2-8	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
used	NULL
in	NULL
the	NULL
assays	NULL
.	NULL

Approximately	NULL
50	NULL
pg	NULL
of	NULL
purified	NULL
human	NULL
NF-xB	NULL
was	NULL
used	NULL
per	NULL
assay	NULL
.	NULL

The	NULL
NF-xB	NULL
was	NULL
purified	NULL
from	NULL
cytosol	NULL
of	NULL
human	NULL
placenta	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
(	NULL
Zabel	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
consisted	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p6S	NULL
subunits	NULL
.	NULL

For	NULL
the	NULL
competition	NULL
experiments	NULL
,	NULL
0.1	NULL
ng	NULL
of	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
was	NULL
mixed	NULL
with	NULL
0.25	NULL
,	NULL
2.5	NULL
and	NULL
25	NULL
ng	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
proteins	NULL
.	NULL

The	NULL
p50	NULL
antiserum	NULL
was	NULL
kindly	NULL
given	NULL
by	NULL
Dr	NULL
A.	NULL
Israel	NULL
(	NULL
Pasteur	NULL
Institute	NULL
,	NULL
Paris	NULL
)	NULL
and	NULL
the	NULL
c-rel	NULL
antiserum	NULL
by	NULL
Dr	NULL
Nancy	NULL
Rice	NULL
(	NULL
NCI	NULL
,	NULL
Frederick	NULL
)	NULL
.	NULL

The	NULL
antisera	NULL
and	NULL
a	NULL
mix	NULL
of	NULL
pre-immune	NULL
sera	NULL
(	NULL
1.5	NULL
l	NULL
)	NULL
were	NULL
diluted	NULL
with	NULL
a	NULL
DNA-binding	NULL
mix	NULL
(	NULL
see	NULL
above	NULL
)	NULL
devoid	NULL
of	NULL
dithiothreitol	NULL
and	NULL
the	NULL
labeled	NULL
DNA	NULL
probe	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
nuclear	NULL
extracts	NULL
or	NULL
purified	NULL
NF-xB	NULL
,	NULL
reactions	NULL
were	NULL
allowed	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Thereafter	NULL
the	NULL
*°P-labeled	NULL
DNA	NULL
probe	NULL
was	NULL
added	NULL
and	NULL
the	NULL
incubation	NULL
continued	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
.	NULL

NAC	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
adjusted	NULL
to	NULL
a	NULL
neutral	NULL
pH	NULL
value	NULL
by	NULL
NaOH	NULL
.	NULL

Oligonucleotides	NULL
and	NULL
plasmid	NULL
constructs	NULL
Oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
synthesizer	NULL
A380	NULL
by	NULL
the	NULL
phosphoroamidate	NULL
method	NULL
and	NULL
purified	NULL
on	NULL
OPC	NULL
cartridges	NULL
{	NULL
Applied	NULL
Biosystems	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
double-stranded	NULL
oligonucleotide	NULL
encompassing	NULL
the	NULL
xB	NULL
motif	NULL
from	NULL
the	NULL
mouse	NULL
x	NULL
light	NULL
chain	NULL
enhancer	NULL
is	NULL
shown	NULL
in	NULL
Zabel	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
to	NULL
detect	NULL
the	NULL
DNA-binding	NULL
activities	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
(	NULL
oct	NULL
)	NULL
,	NULL
AP-1/c-fos	NULL
,	NULL
and	NULL
glucocorticoid	NULL
receptor	NULL
were	NULL
the	NULL
following	NULL
(	NULL
the	NULL
binding	NULL
site	NULL
is	NULL
underlined	NULL
)	NULL
..	NULL
oct	NULL
:	NULL
5'-AGCTTTGGGTAATITGCATTITTCTA-AG-3	NULL
'	NULL
;	NULL
-	NULL
AP-l/c-fos	NULL
:	NULL
5-AGCTTAAAAAAGCATGAGTCAGACACC-TG-3	NULL
'	NULL
;	NULL
glucocorticoid	NULL
receptor	NULL
:	NULL
5'-AGCTTGAGAACACAGTGTTCTGA-TCATGAGAACACAGTGTTCTCG-3	NULL
'	NULL
.	NULL

The	NULL
complementary	NULL
strands	NULL
created	NULL
5'-overhanging	NULL
ends	NULL
(	NULL
Sall	NULL
sites	NULL
)	NULL
which	NULL
allowed	NULL
labeling	NULL
by	NULL
the	NULL
Klenow	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
)	NULL
using	NULL
one	NULL
[	NULL
a-	NULL
>	NULL
P	NULL
]	NULL
dNTP	NULL
(	NULL
Amersham	NULL
,	NULL
3000	NULL
Ci/mmol	NULL
)	NULL
and	NULL
the	NULL
other	NULL
three	NULL
dNTPs	NULL
in	NULL
unlabeled	NULL
form	NULL
.	NULL

The	NULL
labeled	NULL
DNA	NULL
probe	NULL
was	NULL
purified	NULL
on	NULL
push	NULL
columns	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
plasmids	NULL
called	NULL
HIV-LTR	NULL
wt	NULL
and	NULL
HIV-LTR	NULL
mu	NULL
contain	NULL
HIV-1	NULL
sequences	NULL
from	NULL
-453	NULL
to	NULL
+80	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
in	NULL
front	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

In	NULL
the	NULL
HIV-LTR	NULL
mu	NULL
construct	NULL
the	NULL
two	NULL
binding	NULL
sites	NULL
for	NULL
NF-xB	NULL
were	NULL
altered	NULL
by	NULL
mutations	NULL
as	NULL
described	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
,	NULL
transfections	NULL
and	NULL
CAT	NULL
assays	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
penicillin/streptomycin	NULL
(	NULL
all	NULL
purchased	NULL
from	NULL
Gibco	NULL
Laboratories	NULL
)	NULL
.	NULL

The	NULL
medium	NULL
did	NULL
not	NULL
contain	NULL
iron	NULL
salts	NULL
which	NULL
are	NULL
known	NULL
to	NULL
promote	NULL
the	NULL
decomposition	NULL
of	NULL
H	NULL
;	NULL
O	NULL
;	NULL
into	NULL
hydroxyl	NULL
radicals	NULL
.	NULL

IL-18	NULL
was	NULL
purchased	NULL
from	NULL
Genzyme	NULL
(	NULL
Boston	NULL
)	NULL
,	NULL
LPS	NULL
,	NULL
PHA	NULL
,	NULL
PDTC	NULL
,	NULL
NAC	NULL
,	NULL
A23187	NULL
,	NULL
cycloheximide	NULL
and	NULL
PMA	NULL
from	NULL
Sigma	NULL
and	NULL
poly	NULL
(	NULL
rl	NULL
)	NULL
-poly	NULL
(	NULL
rC	NULL
)	NULL
from	NULL
Pharmacia	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
DEAE	NULL
-dextran	NULL
method	NULL
according	NULL
to	NULL
Pomerantz	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
1	NULL
%	NULL
10	NULL
'	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
DEAE-dextran	NULL
(	NULL
Pharmacia	NULL
)	NULL
at	NULL
200	NULL
ug/ml	NULL
!	NULL

and	NULL
15	NULL
ug/ml	NULL
of	NULL
plasmid	NULL
DNA	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
1	NULL
ml	NULL
.	NULL

Incubations	NULL
were	NULL
continued	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
frequent	NULL
agitation	NULL
.	NULL

After	NULL
a	NULL
shock	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
DMSO	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
20	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
20	NULL
h	NULL
with	NULL
recombinant	NULL
human	NULL
TNF-	NULL
@	NULL
(	NULL
30	NULL
ng/ml	NULL
,	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Hofmann	NULL
LaRoche	NULL
,	NULL
Basel	NULL
)	NULL
,	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
PHA	NULL
(	NULL
5	NULL
pg/ml	NULL
;	NULL
both	NULL
Sigma	NULL
)	NULL
or	NULL
H	NULL
,	NULL
O	NULL
;	NULL
(	NULL
Merck	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
and	NULL
protein	NULL
concentrations	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
Biorad	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
Gorman	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
using	NULL
samples	NULL
of	NULL
the	NULL
same	NULL
protein	NULL
content	NULL
.	NULL

In	NULL
a	NULL
reaction	NULL
mix	NULL
of	NULL
150	NULL
al	NULL
containing	NULL
20	NULL
mM	NULL
acetyl	NULL
CoA	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
0.3	NULL
Ci	NULL
[	NULL
+C	NULL
Jchloramphenicol	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
protein	NULL
was	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
followed	NULL
by	NULL
autoradiography	NULL
and	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

Mock	NULL
transfections	NULL
showed	NULL
a	NULL
chloramphenicol	NULL
acetylation	NULL
of	NULL
0.3	NULL
%	NULL
.	NULL

p24	NULL
ELISA	NULL
and	NULL
syncytia	NULL
induction	NULL
assay	NULL
Jurkat	NULL
cells	NULL
(	NULL
3	NULL
x	NULL
10°	NULL
cells/ml	NULL
!	NULL
)	NULL

were	NULL
infected	NULL
with	NULL
10	NULL
IE	NULL
of	NULL
the	NULL
HIV-1	NULL
isolate	NULL
M899	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Prof.	NULL
Dr	NULL
Giirtler	NULL
,	NULL
Pettenkofer	NULL
Institut	NULL
,	NULL
Munich	NULL
)	NULL
.	NULL

On	NULL
day	NULL
8	NULL
post-infection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
.	NULL

On	NULL
day	NULL
eleven	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
50	NULL
ng/ml	NULL
PMA	NULL
,	NULL
50	NULL
aM	NULL
H	NULL
;	NULL
0	NULL
;	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

The	NULL
next	NULL
day	NULL
,	NULL
cell	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
p24	NULL
protein	NULL
in	NULL
the	NULL
supernatants	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
(	NULL
HIVAG-1	NULL
test	NULL
from	NULL
Abott	NULL
GmbH	NULL
,	NULL
Wiesbaden-Delkenheim	NULL
)	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
newly	NULL
produced	NULL
virus	NULL
quantified	NULL
by	NULL
a	NULL
syncytia	NULL
induction	NULL
assay	NULL
using	NULL
C1866	NULL
cells	NULL
(	NULL
Weiss	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
Claudia	NULL
Winter	NULL
and	NULL
Christine	NULL
Federle	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
,	NULL
Dr	NULL
Georg	NULL
Amold	NULL
and	NULL
Inge	NULL
Leitner	NULL
for	NULL
synthesizing	NULL
oligonucleotides	NULL
,	NULL
Cathy	NULL
Schindewolf	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
and	NULL
Prof.	NULL
Dr	NULL
E.-L.	NULL
Winnacker	NULL
for	NULL
his	NULL
continuous	NULL
support	NULL
.	NULL

This	NULL
work	NULL
is	NULL
part	NULL
of	NULL
the	NULL
doctoral	NULL
thesis	NULL
of	NULL
R.S	NULL
.	NULL

and	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
BMFT	NULL
and	NULL
DFG	NULL
(	NULL
SFB	NULL
217	NULL
;	NULL
Ba	NULL
957/1-2	NULL
)	NULL
.	NULL

References	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
Patel	NULL
,	NULL
L.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.J	NULL
.	NULL

III	NULL
and	NULL
Curran	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
,	NULL
249	NULL
,	NULL
1157-1161	NULL
.	NULL

Ananthan	NULL
,	NULL
J.	NULL
,	NULL
Goldberg.A.L	NULL
.	NULL

and	NULL
Voellmy	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
,	NULL
232	NULL
,	NULL
522-524	NULL
.	NULL

Aruoma,0.1	NULL
.	NULL

,	NULL
Halliwell	NULL
,	NULL
B.	NULL
,	NULL
Hoey	NULL
,	NULL
B	NULL
.	NULL

M.	NULL
and	NULL
Butler	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Free	NULL
Radical	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
6	NULL
,	NULL
593-597	NULL
.	NULL

Ashburner	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bonner	NULL
,	NULL
J.J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Cell	NULL
,	NULL
17	NULL
,	NULL
241-254	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1988a	NULL
)	NULL
Cell	NULL
,	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1988b	NULL
)	NULL
Science	NULL
,	NULL
242	NULL
,	NULL
540-546	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
1689-1698	NULL
.	NULL

Bacuerle	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
In	NULL
Cohen	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Foulkes	NULL
,	NULL
J.G	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
Molecular	NULL
Aspects	NULL
of	NULL
Cellular	NULL
Regulation	NULL
,	NULL
Hormonal	NULL
Control	NULL
Regulation	NULL
of	NULL
Gene	NULL
Transcription	NULL
.	NULL

Elsevier/North	NULL
Holland	NULL
Biomedical	NULL
Press	NULL
,	NULL
Amsterdam	NULL
pp	NULL
.	NULL

409-432	NULL
.	NULL

Bacuerie	NULL
,	NULL
P.A	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.W	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
53	NULL
,	NULL
789-798	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J	NULL
.	NULL

W.	NULL
,	NULL
Wano	NULL
,	NULL
Y.	NULL
,	NULL
Franza	NULL
,	NULL
B.R	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
,	NULL
241	NULL
,	NULL
1652-1655	NULL
.	NULL

Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
Walker	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Molitor	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Dixon	NULL
,	NULL
E.P	NULL
.	NULL

,	NULL
Peffer	NULL
,	NULL
N.J.	NULL
,	NULL
Hannink	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
63	NULL
,	NULL
803-814	NULL
.	NULL

Blake	NULL
,	NULL
Allen	NULL
,	NULL
R.E	NULL
.	NULL

and	NULL
Lunec.J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Brit	NULL
.	NULL

Med	NULL
.	NULL

Bull	NULL
.	NULL

,	NULL
43	NULL
,	NULL
371-385	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Burd	NULL
,	NULL
P.R	NULL
.	NULL

,	NULL
Kelly	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
348	NULL
,	NULL
76-80	NULL
.	NULL

Bradford	NULL
.	NULL

M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
72	NULL
.	NULL

248	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
Ruscetti	NULL
,	NULL
F	NULL
.	NULL

W.	NULL
,	NULL
Smith	NULL
,	NULL
R.G	NULL
.	NULL

and	NULL
Rice	NULL
,	NULL
N.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Oncogene	NULL
.	NULL

3	NULL
,	NULL
93-98	NULL
.	NULL

Cerutti	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
,	NULL
227	NULL
,	NULL
375-381	NULL
.	NULL

Activation	NULL
of	NULL
NF-xB	NULL
by	NULL
oxidant	NULL
stress	NULL
Christiansen	NULL
,	NULL
N.O	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
FEBS	NULL
Len	NULL
.	NULL

,	NULL
239	NULL
,	NULL
195-198	NULL
.	NULL

Ciavarra	NULL
,	NULL
R.P	NULL
.	NULL

and	NULL
Simeone	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cellular	NULL
Immunol	NULL
.	NULL

,	NULL
131	NULL
,	NULL
11-26	NULL
.	NULL

Crossin	NULL
,	NULL
K.L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
16	NULL
,	NULL
81-82	NULL
.	NULL

Dignam	NULL
,	NULL
J.P.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
11	NULL
,	NULL
1475-1489	NULL
.	NULL

Duh	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
Maury	NULL
,	NULL
W.J	NULL
.	NULL

,	NULL
Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Fauci	NULL
,	NULL
A.S.	NULL
and	NULL
Rabson	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
5974-5978	NULL
.	NULL

Frei	NULL
,	NULL
B.	NULL
,	NULL
Yamamoto	NULL
,	NULL
Y.	NULL
,	NULL
Niclas	NULL
,	NULL
D.	NULL
and	NULL
Ames	NULL
,	NULL
B.N	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
175	NULL
,	NULL
120-130	NULL
.	NULL

Geelen	NULL
,	NULL
J.L.M.C	NULL
.	NULL

,	NULL
Minnaar	NULL
,	NULL
R.P	NULL
.	NULL

,	NULL
Boom	NULL
,	NULL
R.	NULL
,	NULL
van	NULL
der	NULL
Nordaa	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Goudsmit	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
-	NULL
J.	NULL
Gen	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
2913-2917	NULL
.	NULL

Gennaro.R	NULL
.	NULL

,	NULL
Florio	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Romeo	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
134	NULL
,	NULL
305-312	NULL
.	NULL

Ghosh	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Ghosh	NULL
,	NULL
S..	NULL
Gifford	NULL
,	NULL
A.M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.R	NULL
.	NULL

,	NULL
Tempst	NULL
,	NULL
.P	NULL
.	NULL

,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

Gorman	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Merlino	NULL
,	NULL
G.T	NULL
.	NULL

,	NULL
Willingham	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Pastan,1	NULL
.	NULL

and	NULL
Howard	NULL
,	NULL
B.H	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
79	NULL
,	NULL
6777-6781	NULL
.	NULL

Halliwell	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Gutteridge	NULL
,	NULL
J	NULL
.	NULL

M.C	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Free	NULL
Radicals	NULL
in	NULL
Biology	NULL
and	NULL
Medicine	NULL
.	NULL

Second	NULL
Edition	NULL
.	NULL

Clarendon	NULL
Press	NULL
,	NULL
Oxford	NULL
.	NULL

Halliwell	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Gutteridge	NULL
,	NULL
J.M.C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

,	NULL
186	NULL
,	NULL
1-85	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
Brockhaus	NULL
,	NULL
M.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
,	NULL
Remy	NULL
,	NULL
R.	NULL
,	NULL
Kolbeck	NULL
,	NULL
R	NULL
.	NULL

and	NULL
van	NULL
-	NULL
Loon	NULL
,	NULL
.A.P.G.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
,	NULL
22409-22417	NULL
.	NULL

Johnson	NULL
,	NULL
P.F	NULL
.	NULL

and	NULL
McKnight.S.L	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
58	NULL
,	NULL
799-839	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
,	NULL
4700-4704	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
-	NULL
MB	NULL
.	NULL

,	NULL
Kouriisky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Klebanoff	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Vadas.M.A	NULL
.	NULL

,	NULL
Harlan	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Sparks	NULL
,	NULL
L.H	NULL
.	NULL

,	NULL
Gamble	NULL
,	NULL
J.R.	NULL
,	NULL
Agosti	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Waltersdorph	NULL
,	NULL
A.M.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

,	NULL
136	NULL
,	NULL
4220-4225	NULL
.	NULL

Larrick	NULL
,	NULL
J.W	NULL
.	NULL

and	NULL
Wright	NULL
,	NULL
S.C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
FASEB	NULL
J.	NULL
,	NULL
4	NULL
,	NULL
3215-3223	NULL
.	NULL

Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
Fan	NULL
,	NULL
C.-M.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
57	NULL
,	NULL
287-294	NULL
.	NULL

Leung	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
333	NULL
,	NULL
776-778	NULL
.	NULL

Link	NULL
,	NULL
E.M	NULL
.	NULL

and	NULL
Riley	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

J.	NULL
,	NULL
249	NULL
,	NULL
391-199	NULL
.	NULL

London	NULL
,	NULL
L	NULL
M.	NULL
,	NULL
Levin	NULL
,	NULL
D.H.	NULL
,	NULL
Matts	NULL
,	NULL
R.L	NULL
.	NULL

,	NULL
Thomas	NULL
,	NULL
Pteryshyn	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Chen	NULL
,	NULL
J.-J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
In	NULL
Boyer	NULL
,	NULL
P.D	NULL
.	NULL

and	NULL
Krebs	NULL
,	NULL
E.G	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
The	NULL
Enzymes	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Vol	NULL
.	NULL

18	NULL
,	NULL
pp	NULL
.	NULL

359-380	NULL
.	NULL

Lowenthal	NULL
,	NULL
J	NULL
.	NULL

W.	NULL
,	NULL
Ballard	NULL
,	NULL
Bohnlein	NULL
,	NULL
W.	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
2331-2335	NULL
.	NULL

Matthews	NULL
,	NULL
N.	NULL
,	NULL
Neale.M.L	NULL
.	NULL

,	NULL
Jackson	NULL
,	NULL
S.K	NULL
.	NULL

and	NULL
Stark	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Immunology	NULL
,	NULL
62	NULL
,	NULL
153-155	NULL
.	NULL

Matsubara.T	NULL
.	NULL

and	NULL
Ziff	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
127	NULL
,	NULL
207-210	NULL
.	NULL

Meichle	NULL
,	NULL
A.	NULL
,	NULL
Schiitze	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Hensel	NULL
,	NULL
G.	NULL
,	NULL
Brunsing	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
,	NULL
8339-8343	NULL
.	NULL

Meier	NULL
,	NULL
B.	NULL
,	NULL
Radeke.H.H	NULL
.	NULL

,	NULL
Selle	NULL
,	NULL
S.	NULL
,	NULL
Younes	NULL
,	NULL
M.	NULL
,	NULL
Sies	NULL
,	NULL
H.	NULL
,	NULL
Resch.K	NULL
.	NULL

and	NULL
Habermehl	NULL
,	NULL
G.G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

J.	NULL
,	NULL
263	NULL
,	NULL
539-545	NULL
.	NULL

Meier	NULL
,	NULL
B.	NULL
,	NULL
Radeke	NULL
,	NULL
H.H	NULL
.	NULL

,	NULL
Selle,8	NULL
.	NULL

,	NULL
Habermeh1	NULL
,	NULL
G.G	NULL
.	NULL

,	NULL
Resch	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Sies	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

Hoppe	NULL
Seyler	NULL
,	NULL
371	NULL
,	NULL
1021-1025	NULL
.	NULL

Meltzer	NULL
.	NULL

M.S	NULL
.	NULL

,	NULL
Skillman	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
Hoover	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
Hanson	NULL
,	NULL
B.D	NULL
.	NULL

,	NULL
Turpin	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Kalter.D.C	NULL
.	NULL

and	NULL
Gendelman	NULL
,	NULL
H.E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Immunology	NULL
Today	NULL
,	NULL
11	NULL
,	NULL
217-223	NULL
.	NULL

Messer	NULL
,	NULL
G.	NULL
,	NULL
Weiss	NULL
,	NULL
E.H	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cytokine	NULL
,	NULL
2	NULL
,	NULL
389-397	NULL
.	NULL

Nabel.G	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

Nabel	NULL
,	NULL
G.J	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
344	NULL
,	NULL
178	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
$	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

Pacifici.R.E	NULL
.	NULL

and	NULL
Davies	NULL
.	NULL

K.J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

,	NULL
186	NULL
,	NULL
485-502	NULL
.	NULL

Paul	NULL
,	NULL
N.L	NULL
.	NULL

,	NULL
-	NULL
Lenardo.M.J..	NULL
Novak	NULL
,	NULL
K.D	NULL
.	NULL

,	NULL
Sarr	NULL
,	NULL
T.	NULL
,	NULL
Tang	NULL
,	NULL
W.-L.	NULL
and	NULL
Ruddle	NULL
,	NULL
N.H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
5412-5419	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.J.	NULL
,	NULL
Feinberg	NULL
.	NULL

M.B	NULL
.	NULL

,	NULL
Trono	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
172	NULL
,	NULL
253-261	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
Staal	NULL
,	NULL
F.J.T	NULL
.	NULL

,	NULL
Raju	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Ela	NULL
,	NULL
S.W	NULL
.	NULL

,	NULL
Herzenberg.L	NULL
.	NULL

A.	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
4884-4888	NULL
.	NULL

Rosen	NULL
,	NULL
G.M	NULL
.	NULL

and	NULL
Freeman	NULL
,	NULL
B.A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
81	NULL
,	NULL
7269-7273	NULL
.	NULL

Ruben	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Dillon	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Rosen	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
,	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

Sambucetti	NULL
,	NULL
L.C	NULL
.	NULL

,	NULL
Cherrington	NULL
,	NULL
J	NULL
.	NULL

M..	NULL
Wilkinson	NULL
,	NULL
G	NULL
.	NULL

W.G	NULL
.	NULL

and	NULL
Mocarski	NULL
,	NULL
E.S	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
4251-4258	NULL
.	NULL

Schiitze	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Nottrott	NULL
,	NULL
S.	NULL
,	NULL
Pfizenmaier	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
144	NULL
,	NULL
2604-2608	NULL
.	NULL

Sen	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baltimore.D	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
,	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Shirakawa	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Mizel	NULL
,	NULL
S.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
2424-2430	NULL
.	NULL

2257	NULL
R.Schreck	NULL
,	NULL
P.Rieber	NULL
and	NULL
P.A.Baeuerle	NULL
Staal	NULL
,	NULL
F.J.T	NULL
.	NULL

,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.A.	NULL
and	NULL
Herzenberg	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
9943-9947	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Steffen	NULL
,	NULL
A.	NULL
,	NULL
Litfin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
5169-5181	NULL
.	NULL

Tauber	NULL
,	NULL
A.1I	NULL
.	NULL

,	NULL
Cox	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Curnutte	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
Carrol	NULL
,	NULL
P.M.	NULL
,	NULL
Nakakuma	NULL
,	NULL
H.	NULL
,	NULL
Warren	NULL
,	NULL
B.	NULL
,	NULL
Gilbert	NULL
,	NULL
H.	NULL
and	NULL
Blumberg	NULL
,	NULL
P.M.	NULL
(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

,	NULL
158	NULL
,	NULL
884-890	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
$	NULL
.E	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
142	NULL
,	NULL
702-707	NULL
.	NULL

Twu	NULL
,	NULL
J.-S.	NULL
,	NULL
Chu	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Robinson	NULL
,	NULL
W.S	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
5168-5172	NULL
.	NULL

Urban	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
1975-1984	NULL
.	NULL

Urban	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Schreck	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Valerie.K	NULL
.	NULL

,	NULL
Delers	NULL
,	NULL
A.	NULL
,	NULL
Bruck	NULL
,	NULL
C.	NULL
,	NULL
Thiriart	NULL
,	NULL
C.	NULL
,	NULL
Rosenberg	NULL
,	NULL
H.	NULL
,	NULL
Debouck	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Rosenberg	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
,	NULL
333	NULL
,	NULL
78-81	NULL
.	NULL

Visvanathan	NULL
,	NULL
K.V	NULL
.	NULL

and	NULL
Goodboumn	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
1129-1138	NULL
.	NULL

Weiss	NULL
,	NULL
R.A.	NULL
,	NULL
Clapham	NULL
,	NULL
P.R	NULL
.	NULL

,	NULL
Weber	NULL
,	NULL
J.N	NULL
.	NULL

,	NULL
Dalgleish	NULL
,	NULL
A.G.	NULL
,	NULL
Lasky	NULL
,	NULL
L.A	NULL
.	NULL

and	NULL
Berman	NULL
.	NULL

,	NULL
P.W	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
,	NULL
324	NULL
,	NULL
572-575	NULL
.	NULL

Wong	NULL
,	NULL
G.H	NULL
.	NULL

W.	NULL
,	NULL
Elwell	NULL
,	NULL
J	NULL
.	NULL

H.	NULL
,	NULL
Oberley	NULL
,	NULL
L	NULL
.	NULL

W.	NULL
and	NULL
Goeddel	NULL
,	NULL
D.V	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
58	NULL
,	NULL
923-931	NULL
.	NULL

Wolff	NULL
,	NULL
S.P	NULL
.	NULL

,	NULL
Garner	NULL
,	NULL
A.	NULL
and	NULL
Dean	NULL
,	NULL
R.T	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
11	NULL
,	NULL
27-31	NULL
.	NULL

Zabel	NULL
,	NULL
U	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
61	NULL
,	NULL
255-265	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
Schreck	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
,	NULL
252-260	NULL
.	NULL

Zimarino	NULL
,	NULL
V	NULL
.	NULL

and	NULL
Wu	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
327	NULL
,	NULL
727-730	NULL
.	NULL

Zimmerman	NULL
,	NULL
R.J.	NULL
,	NULL
Marafino	NULL
,	NULL
B.J.Jr	NULL
.	NULL

,	NULL
Chan	NULL
,	NULL
A.	NULL
,	NULL
Landre	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Winkelhake	NULL
,	NULL
J.L	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
142	NULL
,	NULL
1405-1409	NULL
.	NULL

Received	NULL
on	NULL
February	NULL
15	NULL
,	NULL
1991	NULL
;	NULL
revised	NULL
on	NULL
April	NULL
12	NULL
,	NULL
1991	NULL
Note	NULL
added	NULL
in	NULL
proof	NULL
While	NULL
this	NULL
manuscript	NULL
was	NULL
in	NULL
press	NULL
,	NULL
Devary	NULL
et	NULL
al	NULL
.	NULL

(	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
(	NULL
1991	NULL
)	NULL
,	NULL
2804-2811	NULL
)	NULL
also	NULL
reported	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
induced	NULL
with	NULL
H	NULL
;	NULL
O	NULL
;	NULL
treatment	NULL
.	NULL

In	NULL
the	NULL
study	NULL
,	NULL
250	NULL
4M	NULL
H	NULL
;	NULL
O	NULL
;	NULL
was	NULL
used	NULL
for	NULL
stimulation	NULL
which	NULL
might	NULL
be	NULL
the	NULL
reason	NULL
why	NULL
we	NULL
have	NULL
not	NULL
detected	NULL
AP-1	NULL
DNA	NULL
binding	NULL
with	NULL
H	NULL
,	NULL
O	NULL
;	NULL
treatment	NULL
at	NULL
100	NULL
aM	NULL
(	NULL
see	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

2258	NULL

